,genes,description,MF Terms,syngo,syndb,synsysnet,cortex,striatum,fetal,ngn2,Lit Sum,Exp Sum,All Sum
0,LAMC1,laminin subunit gamma 1 [Source:HGNC Symbol;Acc:HGNC:6492],['extracellular matrix constituent conferring elasticity'],1,0,0,0,0,0,1,1,1,2
1,TNR,tenascin R [Source:HGNC Symbol;Acc:HGNC:11953],['signaling receptor binding'],1,1,1,1,1,1,0,3,3,6
2,MYO5A,myosin VA [Source:HGNC Symbol;Acc:HGNC:7602],"['calmodulin binding', 'calcium ion binding', 'small GTPase binding', 'identical protein binding', 'actin filament binding', 'microfilament motor activity', 'ATP binding', 'actin-dependent ATPase activity', 'RNA binding', 'disordered domain specific binding']",1,1,1,1,1,1,1,3,4,7
3,ANO1,anoctamin 1 [Source:HGNC Symbol;Acc:HGNC:21625],"['voltage-gated chloride channel activity', 'calcium activated cation channel activity', 'metal ion binding', 'intracellular calcium activated chloride channel activity', 'protein homodimerization activity', 'iodide transmembrane transporter activity', 'signaling receptor binding']",1,0,0,0,0,0,0,1,0,1
4,FGA,fibrinogen alpha chain [Source:HGNC Symbol;Acc:HGNC:3661],"['extracellular matrix structural constituent', 'metal ion binding', 'cell adhesion molecule binding', 'signaling receptor binding']",1,0,0,0,0,0,0,1,0,1
5,PRKAR2A,protein kinase cAMP-dependent type II regulatory subunit alpha [Source:HGNC Symbol;Acc:HGNC:9391],"['protein kinase A catalytic subunit binding', 'ubiquitin protein ligase binding', 'protein domain specific binding', 'cAMP-dependent protein kinase inhibitor activity', 'cAMP binding']",1,1,1,1,1,1,1,3,4,7
6,PIN1,"peptidylprolyl cis/trans isomerase, NIMA-interacting 1 [Source:HGNC Symbol;Acc:HGNC:8988]","['peptidyl-prolyl cis-trans isomerase activity', 'mitogen-activated protein kinase kinase binding', 'phosphothreonine residue binding', 'GTPase activating protein binding', 'motor activity', 'phosphoserine residue binding', 'tau protein binding', 'beta-catenin binding']",1,0,0,1,1,0,1,1,3,4
7,LZTS1,leucine zipper tumor suppressor 1 [Source:HGNC Symbol;Acc:HGNC:13861],['microtubule binding'],1,1,0,1,0,1,1,2,3,5
8,VPS33B,VPS33B late endosome and lysosome associated [Source:HGNC Symbol;Acc:HGNC:12712],"['protein binding', 'protein-containing complex binding']",1,0,1,1,0,0,1,2,2,4
9,GRIA4,glutamate ionotropic receptor AMPA type subunit 4 [Source:HGNC Symbol;Acc:HGNC:4574],"['amyloid-beta binding', 'AMPA glutamate receptor activity']",1,1,1,1,1,0,0,3,2,5
10,PCLO,piccolo presynaptic cytomatrix protein [Source:HGNC Symbol;Acc:HGNC:13406],"['calcium-dependent phospholipid binding', 'structural constituent of presynaptic active zone', 'calcium ion binding', 'profilin binding']",1,1,1,1,1,1,0,3,3,6
11,JAK2,Janus kinase 2 [Source:HGNC Symbol;Acc:HGNC:6192],"['SH2 domain binding', 'growth hormone receptor binding', 'type 1 angiotensin receptor binding', 'peptide hormone receptor binding', 'histone binding', 'acetylcholine receptor binding', 'protein kinase binding', 'heme binding', 'histone kinase activity (H3-Y41 specific)', 'phosphatidylinositol 3-kinase binding', 'identical protein binding', 'ATP binding', 'metal ion binding', 'insulin receptor substrate binding', 'interleukin-12 receptor binding', 'protein C-terminus binding']",1,0,0,0,0,0,0,1,0,1
12,RPL10,ribosomal protein L10 [Source:HGNC Symbol;Acc:HGNC:10298],"['protein binding', 'RNA binding', 'translation regulator activity', 'structural constituent of ribosome']",1,0,1,1,1,1,1,2,4,6
13,DRP2,dystrophin related protein 2 [Source:HGNC Symbol;Acc:HGNC:3032],['zinc ion binding'],1,0,0,0,0,0,0,1,0,1
14,PPP3CA,protein phosphatase 3 catalytic subunit alpha [Source:HGNC Symbol;Acc:HGNC:9314],"['calmodulin binding', 'calcium ion binding', 'protein dimerization activity', 'protein serine phosphatase activity', 'protein threonine phosphatase activity', 'ATPase binding', 'cyclosporin A binding', 'protein-containing complex binding', 'calmodulin-dependent protein phosphatase activity']",1,1,1,1,1,1,1,3,4,7
15,CHRM3,cholinergic receptor muscarinic 3 [Source:HGNC Symbol;Acc:HGNC:1952],"['G protein-coupled acetylcholine receptor activity', 'protein binding', 'acetylcholine binding', 'phosphatidylinositol phospholipase C activity', 'G protein-coupled serotonin receptor activity']",1,0,0,0,0,0,0,1,0,1
16,GABRA6,gamma-aminobutyric acid type A receptor subunit alpha6 [Source:HGNC Symbol;Acc:HGNC:4080],"['GABA-gated chloride ion channel activity', 'inhibitory extracellular ligand-gated ion channel activity', 'transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential', 'GABA-A receptor activity', 'benzodiazepine receptor activity']",1,0,1,0,0,0,0,2,0,2
17,CHRNA3,cholinergic receptor nicotinic alpha 3 subunit [Source:HGNC Symbol;Acc:HGNC:1957],"['protein binding', 'acetylcholine binding', 'acetylcholine-gated cation-selective channel activity', 'acetylcholine receptor activity']",1,0,0,0,0,0,0,1,0,1
18,TIAM1,TIAM Rac1 associated GEF 1 [Source:HGNC Symbol;Acc:HGNC:11805],"['guanyl-nucleotide exchange factor activity', 'microtubule binding', 'receptor tyrosine kinase binding', 'lipid binding']",1,0,0,1,1,0,0,1,2,3
19,CACNA1A,calcium voltage-gated channel subunit alpha1 A [Source:HGNC Symbol;Acc:HGNC:1388],"['amyloid-beta binding', 'metal ion binding', 'syntaxin binding', 'high voltage-gated calcium channel activity']",1,0,1,1,1,0,0,2,2,4
20,RPL7,ribosomal protein L7 [Source:HGNC Symbol;Acc:HGNC:10363],"['DNA binding', 'identical protein binding', 'structural constituent of ribosome', 'mRNA binding']",1,1,0,1,1,1,1,2,4,6
21,EPS8,epidermal growth factor receptor pathway substrate 8 [Source:HGNC Symbol;Acc:HGNC:3420],"['guanyl-nucleotide exchange factor activity', 'small GTPase binding', 'signaling adaptor activity', 'actin binding']",1,0,0,1,0,0,0,1,1,2
22,PTPRT,protein tyrosine phosphatase receptor type T [Source:HGNC Symbol;Acc:HGNC:9682],"['cadherin binding', 'delta-catenin binding', 'alpha-catenin binding', 'protein homodimerization activity', 'gamma-catenin binding', 'transmembrane receptor protein tyrosine phosphatase activity', 'STAT family protein binding', 'beta-catenin binding', 'protein phosphatase binding']",1,0,0,1,0,0,0,1,1,2
23,SNCA,synuclein alpha [Source:HGNC Symbol;Acc:HGNC:11138],"['zinc ion binding', 'protein kinase inhibitor activity', 'microtubule binding', 'SNARE binding', 'kinesin binding', 'phospholipid binding', 'beta-tubulin binding', 'histone binding', 'cysteine-type endopeptidase inhibitor activity involved in apoptotic process', 'protein domain specific binding', 'Hsp70 protein binding', 'magnesium ion binding', 'cuprous ion binding', 'phosphoprotein binding', 'ferrous iron binding', 'alpha-tubulin binding', 'calcium ion binding', 'oxidoreductase activity', 'actin binding', 'identical protein binding', 'protein N-terminus binding', 'dynein complex binding', 'phospholipase binding', 'transcription regulatory region sequence-specific DNA binding', 'tau protein binding']",1,1,1,1,0,0,0,3,1,4
24,RPL27A,ribosomal protein L27a [Source:HGNC Symbol;Acc:HGNC:10329],"['protein binding', 'RNA binding', 'structural constituent of ribosome']",1,0,0,1,1,1,1,1,4,5
25,CLSTN3,calsyntenin 3 [Source:HGNC Symbol;Acc:HGNC:18371],"['protein binding', 'calcium ion binding']",1,0,0,1,1,0,1,1,3,4
26,GRIN2B,glutamate ionotropic receptor NMDA type subunit 2B [Source:HGNC Symbol;Acc:HGNC:4586],"['zinc ion binding', 'protein binding', 'glutamate-gated calcium ion channel activity', 'glycine binding', 'glutamate binding', 'amyloid-beta binding', 'NMDA glutamate receptor activity']",1,1,1,1,1,1,0,3,3,6
27,CACNA1E,calcium voltage-gated channel subunit alpha1 E [Source:HGNC Symbol;Acc:HGNC:1392],"['calcium ion binding', 'voltage-gated calcium channel activity']",1,0,1,1,1,1,1,2,4,6
28,SV2C,synaptic vesicle glycoprotein 2C [Source:HGNC Symbol;Acc:HGNC:30670],"['protein binding', 'transmembrane transporter activity']",1,1,1,0,0,0,0,3,0,3
29,ATP6V0A4,ATPase H+ transporting V0 subunit a4 [Source:HGNC Symbol;Acc:HGNC:866],"['ATPase binding', 'proton-transporting ATPase activity, rotational mechanism']",1,0,0,0,0,0,0,1,0,1
30,SLC2A3,solute carrier family 2 member 3 [Source:HGNC Symbol;Acc:HGNC:11007],"['protein binding', 'glucose binding', 'glucose transmembrane transporter activity']",1,0,1,0,0,0,1,2,1,3
31,HNRNPH2,heterogeneous nuclear ribonucleoprotein H2 [Source:HGNC Symbol;Acc:HGNC:5042],"['protein binding', 'RNA binding']",1,0,0,1,0,1,1,1,3,4
32,PARN,poly(A)-specific ribonuclease [Source:HGNC Symbol;Acc:HGNC:8609],"[""mRNA 3'-UTR binding"", 'protein kinase binding', 'telomerase RNA binding', 'metal ion binding', 'poly(A)-specific ribonuclease activity']",1,0,0,0,0,0,0,1,0,1
33,RAB7A,"RAB7A, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9788]","['protein binding', 'retromer complex binding', 'GDP binding', 'GTPase activity', 'GTP binding']",1,1,1,1,0,1,1,3,3,6
34,CACNA2D1,calcium voltage-gated channel auxiliary subunit alpha2delta 1 [Source:HGNC Symbol;Acc:HGNC:1399],"['voltage-gated calcium channel activity involved in bundle of His cell action potential', 'metal ion binding']",1,1,1,1,1,1,1,3,4,7
35,ITPKA,inositol-trisphosphate 3-kinase A [Source:HGNC Symbol;Acc:HGNC:6178],"['calmodulin binding', 'inositol-1,4,5-trisphosphate 3-kinase activity', 'calmodulin-dependent protein kinase activity', 'ATP binding', 'small GTPase binding', 'inositol hexakisphosphate kinase activity']",1,0,1,1,1,0,0,2,2,4
36,NETO1,neuropilin and tolloid like 1 [Source:HGNC Symbol;Acc:HGNC:13823],['ionotropic glutamate receptor binding'],1,0,0,1,0,0,0,1,1,2
37,GRM3,glutamate metabotropic receptor 3 [Source:HGNC Symbol;Acc:HGNC:4595],"['scaffold protein binding', 'group II metabotropic glutamate receptor activity', 'calcium channel regulator activity']",1,1,1,1,1,1,0,3,3,6
38,RPL35A,ribosomal protein L35a [Source:HGNC Symbol;Acc:HGNC:10345],"['protein binding', 'tRNA binding', 'structural constituent of ribosome']",1,0,0,1,0,0,0,1,1,2
39,RPS25,ribosomal protein S25 [Source:HGNC Symbol;Acc:HGNC:10413],"['protein binding', 'RNA binding', 'structural constituent of ribosome']",1,1,0,1,1,0,1,2,3,5
40,DNAJB1,DnaJ heat shock protein family (Hsp40) member B1 [Source:HGNC Symbol;Acc:HGNC:5270],"['protein folding chaperone', 'chaperone binding', 'cadherin binding', 'Hsp70 protein binding', 'unfolded protein binding', 'ATPase activator activity', 'transcription corepressor activity', 'ATPase binding']",1,0,0,1,1,1,1,1,4,5
41,RAB3B,"RAB3B, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9778]","['myosin V binding', 'GTP-dependent protein binding', 'GDP binding', 'GTPase activity', 'GTP binding']",1,0,1,1,0,0,0,2,1,3
42,WASF2,WASP family member 2 [Source:HGNC Symbol;Acc:HGNC:12733],"['SH3 domain binding', 'cadherin binding', 'protein kinase A regulatory subunit binding', 'actin binding', 'Arp2/3 complex binding']",1,1,0,0,0,1,0,2,1,3
43,NPY1R,neuropeptide Y receptor Y1 [Source:HGNC Symbol;Acc:HGNC:7956],"['protein binding', 'peptide YY receptor activity', 'pancreatic polypeptide receptor activity']",1,0,0,0,0,0,0,1,0,1
44,PSEN1,presenilin 1 [Source:HGNC Symbol;Acc:HGNC:9508],"['growth factor receptor binding', 'cadherin binding', 'aspartic endopeptidase activity, intramembrane cleaving', 'calcium channel activity', 'ATPase binding', 'PDZ domain binding', 'beta-catenin binding']",1,0,1,0,0,0,0,2,0,2
45,FGB,fibrinogen beta chain [Source:HGNC Symbol;Acc:HGNC:3662],"['chaperone binding', 'extracellular matrix structural constituent', 'cell adhesion molecule binding', 'signaling receptor binding']",1,1,0,0,0,0,0,2,0,2
46,ARHGEF9,Cdc42 guanine nucleotide exchange factor 9 [Source:HGNC Symbol;Acc:HGNC:14561],"['protein binding', 'guanyl-nucleotide exchange factor activity']",1,0,0,0,0,0,0,1,0,1
47,RAB27B,"RAB27B, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9767]","['myosin V binding', 'protein domain specific binding', 'GDP binding', 'GTPase activity', 'GTP binding']",1,0,1,1,0,0,0,2,1,3
48,ACTG1,actin gamma 1 [Source:HGNC Symbol;Acc:HGNC:144],"['ubiquitin protein ligase binding', 'profilin binding', 'identical protein binding', 'ATP binding', 'structural constituent of postsynaptic actin cytoskeleton']",1,1,1,1,1,0,0,3,2,5
49,C1QBP,complement C1q binding protein [Source:HGNC Symbol;Acc:HGNC:1243],"['hyaluronic acid binding', 'mRNA binding', 'transcription factor binding', 'kininogen binding', 'adrenergic receptor binding', 'protein kinase C binding', 'translation activator activity', 'transcription corepressor activity', 'complement component C1q complex binding', 'mitochondrial ribosome binding']",1,1,1,1,0,0,1,3,2,5
50,STX1A,syntaxin 1A [Source:HGNC Symbol;Acc:HGNC:11433],"['ion channel binding', 'SNARE binding', 'SNAP receptor activity', 'calcium channel inhibitor activity', 'chloride channel inhibitor activity', 'calcium-dependent protein binding', 'protein domain specific binding', 'myosin head/neck binding', 'identical protein binding', 'kinase binding', 'protein N-terminus binding', 'protein-containing complex binding', 'ATP-dependent protein binding']",1,1,1,1,1,0,1,3,3,6
51,LRRC7,leucine rich repeat containing 7 [Source:HGNC Symbol;Acc:HGNC:18531],['protein binding'],1,1,1,1,1,1,0,3,3,6
52,SPTAN1,"spectrin alpha, non-erythrocytic 1 [Source:HGNC Symbol;Acc:HGNC:11273]","['calmodulin binding', 'calcium ion binding', 'cadherin binding', 'actin binding', 'structural constituent of cytoskeleton']",1,1,1,1,1,1,1,3,4,7
53,SH3GL2,"SH3 domain containing GRB2 like 2, endophilin A1 [Source:HGNC Symbol;Acc:HGNC:10831]","['identical protein binding', 'protein kinase binding', 'lipid binding', 'protein C-terminus binding']",1,1,1,1,1,1,1,3,4,7
54,RPS11,ribosomal protein S11 [Source:HGNC Symbol;Acc:HGNC:10384],"['protein binding', 'rRNA binding', 'structural constituent of ribosome']",1,0,0,1,1,1,1,1,4,5
55,ABHD17A,"abhydrolase domain containing 17A, depalmitoylase [Source:HGNC Symbol;Acc:HGNC:28756]","['protein binding', 'palmitoyl-(protein) hydrolase activity']",1,0,0,0,0,0,0,1,0,1
56,RPL36,ribosomal protein L36 [Source:HGNC Symbol;Acc:HGNC:13631],"['RNA binding', 'structural constituent of ribosome']",1,1,0,1,1,1,1,2,4,6
57,PPFIA3,PTPRF interacting protein alpha 3 [Source:HGNC Symbol;Acc:HGNC:9247],['protein binding'],1,1,1,1,1,1,1,3,4,7
58,HOMER2,homer scaffold protein 2 [Source:HGNC Symbol;Acc:HGNC:17513],"['G protein-coupled glutamate receptor binding', 'protein domain specific binding', 'actin binding', 'identical protein binding', 'synaptic receptor adaptor activity', 'protein-containing complex binding']",1,1,0,1,1,0,0,2,2,4
59,EPHA3,EPH receptor A3 [Source:HGNC Symbol;Acc:HGNC:3387],"['protein binding', 'GPI-linked ephrin receptor activity', 'transmembrane-ephrin receptor activity', 'ATP binding']",1,0,0,0,0,0,1,1,1,2
60,USP8,ubiquitin specific peptidase 8 [Source:HGNC Symbol;Acc:HGNC:12631],"['thiol-dependent ubiquitin-specific protease activity', 'SH3 domain binding', 'cadherin binding', 'cysteine-type endopeptidase activity']",1,0,0,0,0,0,1,1,1,2
61,HNRNPA2B1,heterogeneous nuclear ribonucleoprotein A2/B1 [Source:HGNC Symbol;Acc:HGNC:5033],"[""mRNA 3'-UTR binding"", 'miRNA binding', 'pre-mRNA intronic binding', 'protein binding', 'N6-methyladenosine-containing RNA binding', 'G-rich strand telomeric DNA binding']",1,0,0,1,1,1,1,1,4,5
62,SNAP91,synaptosome associated protein 91 [Source:HGNC Symbol;Acc:HGNC:14986],"['clathrin heavy chain binding', 'SNARE binding', 'phosphatidylinositol-4,5-bisphosphate binding', 'protein kinase binding', '1-phosphatidylinositol binding']",1,1,1,1,1,1,1,3,4,7
63,ARPC2,actin related protein 2/3 complex subunit 2 [Source:HGNC Symbol;Acc:HGNC:705],"['actin filament binding', 'structural constituent of cytoskeleton']",1,1,0,1,1,1,1,2,4,6
64,DGKI,diacylglycerol kinase iota [Source:HGNC Symbol;Acc:HGNC:2855],"['GTPase inhibitor activity', 'NAD+ kinase activity', 'diacylglycerol kinase activity', 'ATP binding', 'metal ion binding', 'small GTPase binding']",1,0,0,0,0,0,1,1,1,2
65,RELA,"RELA proto-oncogene, NF-kB subunit [Source:HGNC Symbol;Acc:HGNC:9955]","['chromatin DNA binding', 'RNA polymerase II cis-regulatory region sequence-specific DNA binding', 'protein homodimerization activity', 'phosphate ion binding', 'NF-kappaB binding', 'RNA polymerase II core promoter sequence-specific DNA binding', 'histone deacetylase binding', 'actinin binding', 'RNA polymerase II transcription coactivator binding', 'protein kinase binding', 'protein-containing complex binding', 'repressing transcription factor binding', 'protein N-terminus binding', 'DNA-binding transcription activator activity, RNA polymerase II-specific', 'ubiquitin protein ligase binding', 'activating transcription factor binding', 'DNA-binding transcription repressor activity, RNA polymerase II-specific', 'ankyrin repeat binding', 'peptide binding']",1,0,0,0,0,1,1,1,2,3
66,DYNLL2,dynein light chain LC8-type 2 [Source:HGNC Symbol;Acc:HGNC:24596],"['dynein light intermediate chain binding', 'dynein intermediate chain binding', 'scaffold protein binding', 'identical protein binding', 'motor activity', 'protein-containing complex binding']",1,1,1,1,1,0,0,3,2,5
67,EIF4G1,eukaryotic translation initiation factor 4 gamma 1 [Source:HGNC Symbol;Acc:HGNC:3296],"['mRNA binding', 'molecular adaptor activity', 'eukaryotic initiation factor 4E binding', 'translation initiation factor activity', 'identical protein binding', 'ATP binding']",1,1,0,1,1,1,1,2,4,6
68,CHRNA9,cholinergic receptor nicotinic alpha 9 subunit [Source:HGNC Symbol;Acc:HGNC:14079],"['protein binding', 'calcium channel activity', 'acetylcholine-gated cation-selective channel activity', 'transmembrane signaling receptor activity']",1,0,0,0,0,0,0,1,0,1
69,RAB18,"RAB18, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:14244]","['protein binding', 'GDP binding', 'GTP binding', 'GTPase activity']",1,1,1,1,1,0,1,3,3,6
70,NRGN,neurogranin [Source:HGNC Symbol;Acc:HGNC:8000],"['calmodulin binding', 'phosphatidic acid binding', 'phosphatidylinositol-3,4,5-trisphosphate binding']",1,1,1,1,1,0,0,3,2,5
71,BIN1,bridging integrator 1 [Source:HGNC Symbol;Acc:HGNC:1052],"['phospholipid binding', 'chaperone binding', 'clathrin binding', 'aspartic-type endopeptidase inhibitor activity', 'RNA polymerase binding', 'identical protein binding', 'tau protein binding', 'actin filament binding', 'protease binding']",1,1,0,1,1,1,1,2,4,6
72,ATP6V1F,ATPase H+ transporting V1 subunit F [Source:HGNC Symbol;Acc:HGNC:16832],"['protein binding', 'proton-transporting ATPase activity, rotational mechanism', 'ATPase activity']",1,1,1,1,1,0,0,3,2,5
73,GSG1L,GSG1 like [Source:HGNC Symbol;Acc:HGNC:28283],['protein binding'],1,0,0,0,0,0,0,1,0,1
74,PRKACA,protein kinase cAMP-activated catalytic subunit alpha [Source:HGNC Symbol;Acc:HGNC:9380],"['AMP-activated protein kinase activity', 'cAMP-dependent protein kinase activity', 'protein domain specific binding', 'ubiquitin protein ligase binding', 'protein kinase binding', 'manganese ion binding', 'protein kinase A regulatory subunit binding', 'magnesium ion binding', 'protein serine/threonine/tyrosine kinase activity', 'ATP binding']",1,1,1,1,1,1,1,3,4,7
75,PLD1,phospholipase D1 [Source:HGNC Symbol;Acc:HGNC:9067],"['protein binding', 'phosphatidylinositol binding', 'phospholipase D activity', 'N-acylphosphatidylethanolamine-specific phospholipase D activity']",1,0,1,0,0,0,0,2,0,2
76,CADM3,cell adhesion molecule 3 [Source:HGNC Symbol;Acc:HGNC:17601],['protein homodimerization activity'],1,0,0,1,1,1,1,1,4,5
77,GRIA2,glutamate ionotropic receptor AMPA type subunit 2 [Source:HGNC Symbol;Acc:HGNC:4572],"['amyloid-beta binding', 'AMPA glutamate receptor activity', 'protein binding']",1,1,1,1,1,1,1,3,4,7
78,RAB3A,"RAB3A, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9777]","['myosin V binding', 'GTP-dependent protein binding', 'GDP-dissociation inhibitor binding', 'ATPase activator activity', 'GTPase activity', 'ATPase binding', 'GTP binding', 'protein C-terminus binding']",1,1,1,1,1,0,1,3,3,6
79,GIPC1,GIPC PDZ domain containing family member 1 [Source:HGNC Symbol;Acc:HGNC:1226],"['cadherin binding', 'actin binding', 'myosin binding', 'identical protein binding', 'signaling receptor binding']",1,0,0,1,1,0,1,1,3,4
80,SNCB,synuclein beta [Source:HGNC Symbol;Acc:HGNC:11140],"['protein binding', 'phospholipase inhibitor activity', 'calcium ion binding', 'cuprous ion binding']",1,0,1,0,0,0,0,2,0,2
81,CDH1,cadherin 1 [Source:HGNC Symbol;Acc:HGNC:1748],"['calcium ion binding', 'ankyrin binding', 'cadherin binding', 'identical protein binding', 'GTPase activating protein binding', 'gamma-catenin binding', 'beta-catenin binding']",1,0,1,0,0,0,0,2,0,2
82,RAB26,"RAB26, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:14259]","['protein binding', 'GTP binding', 'GMP binding', 'GTPase activity']",1,0,1,0,0,0,0,2,0,2
83,HNRNPM,heterogeneous nuclear ribonucleoprotein M [Source:HGNC Symbol;Acc:HGNC:5046],"['mRNA binding', 'protein domain specific binding']",1,0,0,1,1,1,1,1,4,5
84,RAB11B,"RAB11B, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9761]","['myosin V binding', 'cadherin binding', 'GDP binding', 'GTPase activity', 'GTP binding']",1,0,1,0,0,0,0,2,0,2
85,DMXL2,Dmx like 2 [Source:HGNC Symbol;Acc:HGNC:2938],['small GTPase binding'],1,1,1,1,1,1,1,3,4,7
86,RPL28,ribosomal protein L28 [Source:HGNC Symbol;Acc:HGNC:10330],"['protein binding', 'RNA binding', 'structural constituent of ribosome']",1,0,0,1,1,0,1,1,3,4
87,STX12,syntaxin 12 [Source:HGNC Symbol;Acc:HGNC:11430],"['SNARE binding', 'SNAP receptor activity']",1,1,1,1,1,0,1,3,3,6
88,RPL13,ribosomal protein L13 [Source:HGNC Symbol;Acc:HGNC:10303],"['protein binding', 'RNA binding', 'structural constituent of ribosome']",1,1,1,1,1,1,1,3,4,7
89,GAD1,glutamate decarboxylase 1 [Source:HGNC Symbol;Acc:HGNC:4092],"['glutamate decarboxylase activity', 'glutamate binding', 'protein N-terminus binding', 'pyridoxal phosphate binding', 'protein-containing complex binding']",1,1,0,1,1,0,0,2,2,4
90,NR3C2,nuclear receptor subfamily 3 group C member 2 [Source:HGNC Symbol;Acc:HGNC:7979],"['zinc ion binding', 'steroid binding', 'protein binding', 'RNA polymerase II cis-regulatory region sequence-specific DNA binding', 'nuclear receptor activity', 'steroid hormone receptor activity']",1,0,0,0,0,0,0,1,0,1
91,SV2A,synaptic vesicle glycoprotein 2A [Source:HGNC Symbol;Acc:HGNC:20566],"['transmembrane transporter activity', 'protein kinase binding']",1,1,1,1,1,0,1,3,3,6
92,RPL22,ribosomal protein L22 [Source:HGNC Symbol;Acc:HGNC:10315],"['RNA binding', 'identical protein binding', 'heparin binding', 'structural constituent of ribosome']",1,1,0,1,1,1,1,2,4,6
93,ZDHHC5,zinc finger DHHC-type palmitoyltransferase 5 [Source:HGNC Symbol;Acc:HGNC:18472],"['protein binding', 'protein-cysteine S-palmitoyltransferase activity']",1,0,0,1,0,0,1,1,2,3
94,GRM4,glutamate metabotropic receptor 4 [Source:HGNC Symbol;Acc:HGNC:4596],['group III metabotropic glutamate receptor activity'],1,0,1,1,0,0,0,2,1,3
95,RIMS1,regulating synaptic membrane exocytosis 1 [Source:HGNC Symbol;Acc:HGNC:17282],"['ion channel binding', 'GTPase regulator activity', 'small GTPase binding', 'metal ion binding', 'RNA binding']",1,1,1,1,1,1,1,3,4,7
96,ELAVL1,ELAV like RNA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:3312],"['miRNA binding', ""mRNA 3'-UTR AU-rich region binding"", 'protein kinase binding', 'double-stranded RNA binding', 'protein homodimerization activity']",1,0,0,1,0,1,1,1,3,4
97,GDI2,GDP dissociation inhibitor 2 [Source:HGNC Symbol;Acc:HGNC:4227],"['GTPase activator activity', 'RNA binding', 'Rab GDP-dissociation inhibitor activity', 'small GTPase binding']",1,1,1,1,0,1,1,3,3,6
98,DAGLA,diacylglycerol lipase alpha [Source:HGNC Symbol;Acc:HGNC:1165],"['protein binding', 'hydrolase activity', 'metal ion binding']",1,0,0,1,0,0,0,1,1,2
99,DGCR8,DGCR8 microprocessor complex subunit [Source:HGNC Symbol;Acc:HGNC:2847],"['primary miRNA binding', 'ribonuclease III activity', 'double-stranded RNA binding', 'heme binding', 'protein homodimerization activity', 'metal ion binding']",1,0,0,0,0,0,0,1,0,1
100,DBNL,drebrin like [Source:HGNC Symbol;Acc:HGNC:2696],"['cadherin binding', 'protein domain specific binding', 'actin filament binding', 'enzyme activator activity', 'protein C-terminus binding']",1,1,1,1,1,0,1,3,3,6
101,AKAP1,A-kinase anchoring protein 1 [Source:HGNC Symbol;Acc:HGNC:367],"['RNA binding', 'protein kinase A regulatory subunit binding']",1,0,0,0,1,0,1,1,2,3
102,RPL36A,ribosomal protein L36a [Source:HGNC Symbol;Acc:HGNC:10359],"['protein binding', 'RNA binding', 'structural constituent of ribosome']",1,0,0,1,1,0,0,1,2,3
103,RTN4,reticulon 4 [Source:HGNC Symbol;Acc:HGNC:14085],"['ubiquitin protein ligase binding', 'RNA binding', 'cadherin binding']",1,1,1,1,1,1,1,3,4,7
104,TAOK2,TAO kinase 2 [Source:HGNC Symbol;Acc:HGNC:16835],"['protein serine kinase activity', 'mitogen-activated protein kinase kinase binding', 'neuropilin binding', 'ATP binding', 'tau-protein kinase activity', 'protein threonine kinase activity', 'tau protein binding', 'MAP kinase kinase kinase activity']",1,1,0,1,0,0,1,2,2,4
105,PCDH8,protocadherin 8 [Source:HGNC Symbol;Acc:HGNC:8660],['calcium ion binding'],1,0,0,0,0,0,0,1,0,1
106,ATP2B2,ATPase plasma membrane Ca2+ transporting 2 [Source:HGNC Symbol;Acc:HGNC:815],"['calmodulin binding', 'PDZ domain binding', 'calcium-transporting ATPase activity involved in regulation of postsynaptic cytosolic calcium ion concentration', 'ATP binding', 'metal ion binding', 'calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration']",1,1,1,1,1,0,1,3,3,6
107,BCL11A,BAF chromatin remodeling complex subunit BCL11A [Source:HGNC Symbol;Acc:HGNC:13221],"['RNA polymerase II cis-regulatory region sequence-specific DNA binding', 'protein kinase binding', 'DNA-binding transcription repressor activity, RNA polymerase II-specific', 'metal ion binding']",1,0,0,0,0,0,0,1,0,1
108,SLC18A1,solute carrier family 18 member A1 [Source:HGNC Symbol;Acc:HGNC:10934],"['serotonin:sodium symporter activity', 'xenobiotic transmembrane transporter activity']",1,0,1,0,0,0,0,2,0,2
109,CDH6,cadherin 6 [Source:HGNC Symbol;Acc:HGNC:1765],"['cadherin binding', 'calcium ion binding']",1,0,1,1,0,0,1,2,2,4
110,CLTC,clathrin heavy chain [Source:HGNC Symbol;Acc:HGNC:2092],"['protein kinase binding', 'double-stranded RNA binding', 'low-density lipoprotein particle receptor binding', 'clathrin light chain binding', 'structural molecule activity', 'ubiquitin-specific protease binding', 'disordered domain specific binding']",1,1,1,0,0,1,1,3,2,5
111,AMPH,amphiphysin [Source:HGNC Symbol;Acc:HGNC:471],"['protein binding', 'phospholipid binding']",1,1,1,1,1,1,1,3,4,7
112,STXBP5L,syntaxin binding protein 5 like [Source:HGNC Symbol;Acc:HGNC:30757],"['GTPase activator activity', 'small GTPase binding', 'syntaxin binding', 'myosin II binding']",1,0,1,1,0,0,0,2,1,3
113,STAT3,signal transducer and activator of transcription 3 [Source:HGNC Symbol;Acc:HGNC:11364],"['primary miRNA binding', 'CCR5 chemokine receptor binding', 'DNA-binding transcription activator activity, RNA polymerase II-specific', 'chromatin DNA binding', 'RNA polymerase II cis-regulatory region sequence-specific DNA binding', 'glucocorticoid receptor binding', 'protein kinase binding', 'RNA polymerase II repressing transcription factor binding', 'protein homodimerization activity', 'nuclear receptor activity', 'protein phosphatase binding']",1,0,0,1,0,0,1,1,2,3
114,SLC29A1,solute carrier family 29 member 1 (Augustine blood group) [Source:HGNC Symbol;Acc:HGNC:11003],"['uridine transmembrane transporter activity', 'purine nucleoside transmembrane transporter activity', 'neurotransmitter transmembrane transporter activity']",1,0,0,0,0,1,0,1,1,2
115,LPAR2,lysophosphatidic acid receptor 2 [Source:HGNC Symbol;Acc:HGNC:3168],"['protein binding', 'lysophosphatidic acid receptor activity', 'lipid binding']",1,0,0,0,0,0,0,1,0,1
116,PTK2B,protein tyrosine kinase 2 beta [Source:HGNC Symbol;Acc:HGNC:9612],"['3-phosphoinositide-dependent protein kinase binding', 'ubiquitin protein ligase binding', 'calmodulin-dependent protein kinase activity', 'non-membrane spanning protein tyrosine kinase activity', 'ATP binding', 'protein-containing complex binding', 'protein C-terminus binding', 'NMDA glutamate receptor activity', 'signaling receptor binding']",1,1,0,1,0,0,0,2,1,3
117,GABBR1,gamma-aminobutyric acid type B receptor subunit 1 [Source:HGNC Symbol;Acc:HGNC:4070],"['protein binding', 'G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential', 'G protein-coupled GABA receptor activity']",1,1,1,1,1,1,1,3,4,7
118,PSEN2,presenilin 2 [Source:HGNC Symbol;Acc:HGNC:9509],"['protein binding', 'aspartic endopeptidase activity, intramembrane cleaving']",1,0,1,0,0,0,0,2,0,2
119,EIF4E,eukaryotic translation initiation factor 4E [Source:HGNC Symbol;Acc:HGNC:3287],"['RNA 7-methylguanosine cap binding', 'eukaryotic initiation factor 4G binding', 'enzyme binding', 'translation initiation factor activity', 'repressing transcription factor binding']",1,1,0,1,0,0,1,2,2,4
120,DRD3,dopamine receptor D3 [Source:HGNC Symbol;Acc:HGNC:3024],"['protein domain specific binding', 'G protein-coupled receptor activity', 'D1 dopamine receptor binding', 'dopamine binding', 'dopamine neurotransmitter receptor activity, coupled via Gi/Go', 'drug binding']",1,0,0,0,0,0,0,1,0,1
121,SLC6A4,solute carrier family 6 member 4 [Source:HGNC Symbol;Acc:HGNC:11050],"['nitric-oxide synthase binding', 'serotonin:sodium symporter activity', 'serotonin binding', 'identical protein binding', 'actin filament binding', 'cocaine binding', 'syntaxin-1 binding', 'metal ion binding', 'neurotransmitter transmembrane transporter activity']",1,0,1,0,0,0,0,2,0,2
122,RPL14,ribosomal protein L14 [Source:HGNC Symbol;Acc:HGNC:10305],"['RNA binding', 'cadherin binding', 'structural constituent of ribosome']",1,1,0,1,1,1,1,2,4,6
123,MYH10,myosin heavy chain 10 [Source:HGNC Symbol;Acc:HGNC:7568],"['calmodulin binding', 'ADP binding', 'RNA stem-loop binding', ""mRNA 5'-UTR binding"", 'actin filament binding', 'microfilament motor activity', 'ATP binding', 'actin-dependent ATPase activity']",1,1,1,1,1,1,1,3,4,7
124,RNF10,ring finger protein 10 [Source:HGNC Symbol;Acc:HGNC:10055],"['protein binding', 'ubiquitin protein ligase activity', 'transcription regulatory region sequence-specific DNA binding', 'metal ion binding']",1,0,0,0,0,0,0,1,0,1
125,FZD9,frizzled class receptor 9 [Source:HGNC Symbol;Acc:HGNC:4047],"['Wnt-protein binding', 'Wnt-activated receptor activity', 'G protein-coupled receptor activity', 'protein homodimerization activity', 'protein heterodimerization activity']",1,0,0,0,0,0,0,1,0,1
126,NRXN1,neurexin 1 [Source:HGNC Symbol;Acc:HGNC:8008],"['calcium ion binding', 'signaling receptor activity', 'neuroligin family protein binding', 'acetylcholine receptor binding', 'calcium channel regulator activity', 'cell adhesion molecule binding']",1,1,1,1,1,1,1,3,4,7
127,PPFIA2,PTPRF interacting protein alpha 2 [Source:HGNC Symbol;Acc:HGNC:9246],"['protein binding', 'structural constituent of presynapse']",1,1,1,1,1,1,1,3,4,7
128,SCN2A,sodium voltage-gated channel alpha subunit 2 [Source:HGNC Symbol;Acc:HGNC:10588],"['voltage-gated sodium channel activity', 'protein binding', 'voltage-gated ion channel activity']",1,1,1,0,0,0,1,3,1,4
129,RPS26,ribosomal protein S26 [Source:HGNC Symbol;Acc:HGNC:10414],"['mRNA binding', 'cadherin binding', 'structural constituent of ribosome']",1,0,0,1,0,1,1,1,3,4
130,ITSN1,intersectin 1 [Source:HGNC Symbol;Acc:HGNC:6183],"['guanyl-nucleotide exchange factor activity', 'molecular adaptor activity', 'calcium ion binding', 'proline-rich region binding']",1,0,0,1,1,1,1,1,4,5
131,ATP6V1H,ATPase H+ transporting V1 subunit H [Source:HGNC Symbol;Acc:HGNC:18303],"['protein binding', 'proton-transporting ATPase activity, rotational mechanism', 'ATPase activity', 'enzyme regulator activity']",1,1,1,1,1,1,1,3,4,7
132,HIP1R,huntingtin interacting protein 1 related [Source:HGNC Symbol;Acc:HGNC:18415],"['SH3 domain binding', 'phosphatidylinositol-4,5-bisphosphate binding', 'phosphatidylinositol-3,5-bisphosphate binding', 'clathrin light chain binding', 'protein homodimerization activity', 'actin filament binding', 'phosphatidylinositol-3,4,5-trisphosphate binding', 'clathrin adaptor activity', 'phosphatidylinositol-3,4-bisphosphate binding', 'protein heterodimerization activity']",1,1,0,1,1,1,1,2,4,6
133,SLC8A2,solute carrier family 8 member A2 [Source:HGNC Symbol;Acc:HGNC:11069],"['calmodulin binding', 'calcium:sodium antiporter activity', 'calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration', 'metal ion binding']",1,0,1,0,0,0,1,2,1,3
134,CAMK2A,calcium/calmodulin dependent protein kinase II alpha [Source:HGNC Symbol;Acc:HGNC:1460],"['calmodulin binding', 'glutamate receptor binding', 'calmodulin-dependent protein kinase activity', 'protein homodimerization activity', 'calcium-dependent protein serine/threonine kinase activity', 'ATP binding', 'metal ion binding']",1,1,1,1,1,1,0,3,3,6
135,PIP5K1C,phosphatidylinositol-4-phosphate 5-kinase type 1 gamma [Source:HGNC Symbol;Acc:HGNC:8996],"['protein binding', '1-phosphatidylinositol-4-phosphate 5-kinase activity', 'ATP binding']",1,1,1,1,0,0,1,3,2,5
136,SPTB,"spectrin beta, erythrocytic [Source:HGNC Symbol;Acc:HGNC:11274]","['ankyrin binding', 'actin filament binding', 'structural constituent of cytoskeleton']",1,1,1,1,1,0,0,3,2,5
137,RPS15A,ribosomal protein S15a [Source:HGNC Symbol;Acc:HGNC:10389],"['protein binding', 'RNA binding', 'structural constituent of ribosome']",1,1,0,1,0,0,0,2,1,3
138,HPCA,hippocalcin [Source:HGNC Symbol;Acc:HGNC:5144],"['identical protein binding', 'kinase binding', 'calcium ion binding', 'actin binding']",1,1,1,0,0,0,0,3,0,3
139,DGKB,diacylglycerol kinase beta [Source:HGNC Symbol;Acc:HGNC:2850],"['calcium ion binding', 'lipid binding', 'NAD+ kinase activity', 'diacylglycerol kinase activity', 'ATP binding']",1,1,0,1,1,0,0,2,2,4
140,ELAVL2,ELAV like RNA binding protein 2 [Source:HGNC Symbol;Acc:HGNC:3313],"[""mRNA 3'-UTR binding"", 'protein binding']",1,0,0,1,0,1,1,1,3,4
141,ACTR2,actin related protein 2 [Source:HGNC Symbol;Acc:HGNC:169],"['actin filament binding', 'structural constituent of cytoskeleton', 'ATP binding']",1,1,1,1,1,1,1,3,4,7
142,FXR1,FMR1 autosomal homolog 1 [Source:HGNC Symbol;Acc:HGNC:4023],"[""mRNA 3'-UTR binding"", 'protein homodimerization activity', 'translation regulator activity', 'protein heterodimerization activity', 'RNA strand annealing activity']",1,0,0,1,0,1,1,1,3,4
143,CAMK2B,calcium/calmodulin dependent protein kinase II beta [Source:HGNC Symbol;Acc:HGNC:1461],"['calmodulin binding', 'calmodulin-dependent protein kinase activity', 'actin binding', 'protein homodimerization activity', 'ATP binding']",1,1,1,1,1,1,1,3,4,7
144,DVL1,dishevelled segment polarity protein 1 [Source:HGNC Symbol;Acc:HGNC:3084],"['protein kinase binding', 'identical protein binding', 'small GTPase binding', 'frizzled binding', 'beta-catenin binding']",1,0,1,0,0,0,1,2,1,3
145,KCNJ11,potassium inwardly rectifying channel subfamily J member 11 [Source:HGNC Symbol;Acc:HGNC:6257],"['ion channel binding', 'ATPase-coupled cation transmembrane transporter activity', 'ankyrin binding', 'heat shock protein binding', 'potassium ion binding', 'ATP-activated inward rectifier potassium channel activity', 'ATP binding', 'protein C-terminus binding']",1,0,0,0,0,0,0,1,0,1
146,CSPG5,chondroitin sulfate proteoglycan 5 [Source:HGNC Symbol;Acc:HGNC:2467],['growth factor activity'],1,1,1,1,1,0,0,3,2,5
147,STON2,stonin 2 [Source:HGNC Symbol;Acc:HGNC:30652],['clathrin adaptor activity'],1,1,0,0,0,0,1,2,1,3
148,NAPG,NSF attachment protein gamma [Source:HGNC Symbol;Acc:HGNC:7642],"['soluble NSF attachment protein activity', 'syntaxin binding']",1,1,1,1,1,0,1,3,3,6
149,TANC2,"tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 [Source:HGNC Symbol;Acc:HGNC:30212]",None,1,0,0,1,1,1,1,1,4,5
150,TSC2,TSC complex subunit 2 [Source:HGNC Symbol;Acc:HGNC:12363],"['GTPase activator activity', 'phosphatase binding', 'protein homodimerization activity', 'Hsp90 protein binding', 'small GTPase binding']",1,1,0,1,0,1,1,2,3,5
151,CLSTN1,calsyntenin 1 [Source:HGNC Symbol;Acc:HGNC:17447],"['amyloid-beta binding', 'kinesin binding', 'X11-like protein binding', 'calcium ion binding']",1,0,0,1,0,0,0,1,1,2
152,DTNBP1,dystrobrevin binding protein 1 [Source:HGNC Symbol;Acc:HGNC:17328],['protein binding'],1,0,0,0,0,0,0,1,0,1
153,AP3D1,adaptor related protein complex 3 subunit delta 1 [Source:HGNC Symbol;Acc:HGNC:568],['protein binding'],1,1,1,1,1,1,1,3,4,7
154,RIMBP2,RIMS binding protein 2 [Source:HGNC Symbol;Acc:HGNC:30339],None,1,1,1,1,1,0,0,3,2,5
155,RPS19,ribosomal protein S19 [Source:HGNC Symbol;Acc:HGNC:10402],"['fibroblast growth factor binding', 'protein kinase binding', 'identical protein binding', 'structural constituent of ribosome', 'RNA binding']",1,0,0,1,1,0,1,1,3,4
156,PUM1,pumilio RNA binding family member 1 [Source:HGNC Symbol;Acc:HGNC:14957],"[""mRNA 3'-UTR binding"", 'protein binding', 'miRNA binding']",1,0,0,0,0,0,0,1,0,1
157,VAMP4,vesicle associated membrane protein 4 [Source:HGNC Symbol;Acc:HGNC:12645],['protein binding'],1,0,1,1,0,0,0,2,1,3
158,UNC13B,unc-13 homolog B [Source:HGNC Symbol;Acc:HGNC:12566],"['calmodulin binding', 'phospholipid binding', 'calcium ion binding', 'GTP-dependent protein binding', 'syntaxin-1 binding', 'small GTPase binding', 'diacylglycerol binding']",1,0,1,1,0,1,1,2,3,5
159,ADRA2A,adrenoceptor alpha 2A [Source:HGNC Symbol;Acc:HGNC:281],"['epinephrine binding', 'norepinephrine binding', 'alpha-1B adrenergic receptor binding', 'protein kinase binding', 'heterotrimeric G-protein binding', 'thioesterase binding', 'protein homodimerization activity', 'alpha2-adrenergic receptor activity', 'alpha-2C adrenergic receptor binding', 'protein heterodimerization activity']",1,0,1,1,0,1,0,2,2,4
160,STX16,syntaxin 16 [Source:HGNC Symbol;Acc:HGNC:11431],"['SNAP receptor activity', 'syntaxin binding']",1,1,1,1,0,0,0,3,1,4
161,RPS2,ribosomal protein S2 [Source:HGNC Symbol;Acc:HGNC:10404],"['mRNA binding', 'fibroblast growth factor binding', 'cadherin binding', 'enzyme binding', 'structural constituent of ribosome']",1,1,0,1,1,1,1,2,4,6
162,SLITRK3,SLIT and NTRK like family member 3 [Source:HGNC Symbol;Acc:HGNC:23501],['protein binding'],1,0,0,0,0,0,0,1,0,1
163,RPL30,ribosomal protein L30 [Source:HGNC Symbol;Acc:HGNC:10333],"['protein binding', 'RNA binding', 'structural constituent of ribosome']",1,1,0,1,1,1,1,2,4,6
164,SNAPIN,SNAP associated protein [Source:HGNC Symbol;Acc:HGNC:17145],['SNARE binding'],1,0,1,0,0,0,0,2,0,2
165,CANX,calnexin [Source:HGNC Symbol;Acc:HGNC:1473],"['calcium ion binding', 'apolipoprotein binding', 'carbohydrate binding', 'unfolded protein binding', 'RNA binding', 'ionotropic glutamate receptor binding']",1,1,1,1,1,1,1,3,4,7
166,SLC2A4,solute carrier family 2 member 4 [Source:HGNC Symbol;Acc:HGNC:11009],"['protein binding', 'D-glucose transmembrane transporter activity']",1,0,0,0,0,0,0,1,0,1
167,SORCS3,sortilin related VPS10 domain containing receptor 3 [Source:HGNC Symbol;Acc:HGNC:16699],"['protein binding', 'neuropeptide receptor activity']",1,0,0,0,0,0,0,1,0,1
168,KCNH1,potassium voltage-gated channel subfamily H member 1 [Source:HGNC Symbol;Acc:HGNC:6250],"['calmodulin binding', 'delayed rectifier potassium channel activity', 'phosphatidylinositol bisphosphate binding']",1,0,0,0,0,0,0,1,0,1
169,SGTA,small glutamine rich tetratricopeptide repeat containing alpha [Source:HGNC Symbol;Acc:HGNC:10819],"['molecular adaptor activity', 'identical protein binding', 'BAT3 complex binding', 'protein self-association']",1,1,0,1,0,1,1,2,3,5
170,ALDOC,"aldolase, fructose-bisphosphate C [Source:HGNC Symbol;Acc:HGNC:418]","['fructose-bisphosphate aldolase activity', 'cytoskeletal protein binding']",1,1,0,1,1,1,1,2,4,6
171,RPS23,ribosomal protein S23 [Source:HGNC Symbol;Acc:HGNC:10410],"['protein binding', 'RNA binding', 'structural constituent of ribosome']",1,0,0,1,1,0,1,1,3,4
172,ADD1,adducin 1 [Source:HGNC Symbol;Acc:HGNC:243],"['calmodulin binding', 'transcription factor binding', 'spectrin binding', 'cadherin binding', 'protein homodimerization activity', 'actin filament binding', 'RNA binding', 'protein heterodimerization activity', 'structural constituent of cytoskeleton']",1,1,1,1,1,1,1,3,4,7
173,DLG1,discs large MAGUK scaffold protein 1 [Source:HGNC Symbol;Acc:HGNC:2900],"['ion channel binding', 'molecular adaptor activity', 'phosphoprotein phosphatase activity', 'structural constituent of postsynaptic density', 'mitogen-activated protein kinase kinase binding', 'cadherin binding', 'L27 domain binding', 'phosphatase binding', 'cytoskeletal protein binding', 'guanylate kinase activity', 'potassium channel regulator activity', 'protein C-terminus binding']",1,1,1,1,1,0,1,3,3,6
174,DAPK1,death associated protein kinase 1 [Source:HGNC Symbol;Acc:HGNC:2674],"['calmodulin binding', 'protein serine kinase activity', 'calmodulin-dependent protein kinase activity', 'identical protein binding', 'syntaxin-1 binding', 'ATP binding', 'protein threonine kinase activity', 'GTP binding']",1,0,1,0,0,1,1,2,2,4
175,CASKIN1,CASK interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:20879],['identical protein binding'],1,1,1,1,1,1,1,3,4,7
176,PENK,proenkephalin [Source:HGNC Symbol;Acc:HGNC:8831],"['opioid peptide activity', 'opioid receptor binding', 'neuropeptide hormone activity']",1,0,1,0,0,0,0,2,0,2
177,DOC2A,double C2 domain alpha [Source:HGNC Symbol;Acc:HGNC:2985],"['protein binding', 'calcium ion binding', 'calcium-dependent phospholipid binding']",1,1,1,1,0,0,0,3,1,4
178,ARHGEF2,Rho/Rac guanine nucleotide exchange factor 2 [Source:HGNC Symbol;Acc:HGNC:682],"['transcription factor binding', 'zinc ion binding', 'small GTPase binding', 'microtubule binding', 'guanyl-nucleotide exchange factor activity']",1,1,0,1,1,1,1,2,4,6
179,ADD2,adducin 2 [Source:HGNC Symbol;Acc:HGNC:244],"['calmodulin binding', 'spectrin binding', 'protein kinase binding', 'protein homodimerization activity', 'actin filament binding', 'protein heterodimerization activity', 'structural constituent of cytoskeleton']",1,1,1,1,1,1,1,3,4,7
180,RAB1A,"RAB1A, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9758]","['cadherin binding', 'GTP binding', 'GTPase activity']",1,1,1,1,0,0,1,3,2,5
181,NAPB,NSF attachment protein beta [Source:HGNC Symbol;Acc:HGNC:15751],"['soluble NSF attachment protein activity', 'syntaxin binding']",1,1,1,1,1,1,1,3,4,7
182,RPS6KC1,ribosomal protein S6 kinase C1 [Source:HGNC Symbol;Acc:HGNC:10439],"['protein serine kinase activity', 'protein binding', 'phosphatidylinositol binding', 'ATP binding', 'protein threonine kinase activity']",1,0,0,1,0,0,0,1,1,2
183,SLC6A9,solute carrier family 6 member 9 [Source:HGNC Symbol;Acc:HGNC:11056],['glycine:sodium symporter activity'],1,0,1,0,0,0,0,2,0,2
184,ATP2B3,ATPase plasma membrane Ca2+ transporting 3 [Source:HGNC Symbol;Acc:HGNC:816],"['calmodulin binding', 'PDZ domain binding', 'ATP binding', 'metal ion binding', 'calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration']",1,1,1,0,0,0,1,3,1,4
185,DVL3,dishevelled segment polarity protein 3 [Source:HGNC Symbol;Acc:HGNC:3087],"['small GTPase binding', 'frizzled binding', 'protease binding', 'beta-catenin binding']",1,0,0,0,0,0,1,1,1,2
186,ATP6AP1,ATPase H+ transporting accessory protein 1 [Source:HGNC Symbol;Acc:HGNC:868],"['small GTPase binding', 'ATP binding']",1,0,1,0,0,0,1,2,1,3
187,STX4,syntaxin 4 [Source:HGNC Symbol;Acc:HGNC:11439],"['sphingomyelin phosphodiesterase activator activity', 'SNARE binding', 'SNAP receptor activity']",1,1,1,0,0,0,1,3,1,4
188,ITGB1,integrin subunit beta 1 [Source:HGNC Symbol;Acc:HGNC:6153],"['protein tyrosine kinase binding', 'virus receptor activity', 'cadherin binding', 'collagen binding involved in cell-matrix adhesion', 'fibronectin binding', 'actin binding', 'integrin binding', 'coreceptor activity', 'metal ion binding', 'C-X3-C chemokine binding', 'protein heterodimerization activity', 'protease binding', 'laminin binding']",1,0,0,0,0,0,1,1,1,2
189,NGDN,neuroguidin [Source:HGNC Symbol;Acc:HGNC:20271],"['protein binding', 'RNA binding']",1,0,0,0,0,0,0,1,0,1
190,CYTH1,cytohesin 1 [Source:HGNC Symbol;Acc:HGNC:9501],"['protein binding', 'guanyl-nucleotide exchange factor activity', 'lipid binding']",1,0,0,1,0,0,1,1,2,3
191,RPLP2,ribosomal protein lateral stalk subunit P2 [Source:HGNC Symbol;Acc:HGNC:10377],"['protein binding', 'structural constituent of ribosome']",1,0,0,1,1,1,0,1,3,4
192,PPP2R1B,protein phosphatase 2 scaffold subunit Abeta [Source:HGNC Symbol;Acc:HGNC:9303],"['protein serine/threonine phosphatase activity', 'protein binding', 'protein phosphatase regulator activity']",1,0,0,1,1,0,1,1,3,4
193,PABPC1,poly(A) binding protein cytoplasmic 1 [Source:HGNC Symbol;Acc:HGNC:8554],"[""mRNA 3'-UTR binding"", 'poly(A) binding', 'translation activator activity', 'poly(U) RNA binding', 'protein C-terminus binding']",1,1,0,1,1,1,1,2,4,6
194,ANKS1B,ankyrin repeat and sterile alpha motif domain containing 1B [Source:HGNC Symbol;Acc:HGNC:24600],['ephrin receptor binding'],1,1,0,1,1,1,0,2,3,5
195,SNX1,sorting nexin 1 [Source:HGNC Symbol;Acc:HGNC:11172],"['epidermal growth factor receptor binding', 'leptin receptor binding', 'cadherin binding', 'phosphatidylinositol binding', 'insulin receptor binding', 'protein homodimerization activity', 'protein heterodimerization activity', 'transferrin receptor binding']",1,1,0,1,0,0,1,2,2,4
196,RPL7A,ribosomal protein L7a [Source:HGNC Symbol;Acc:HGNC:10364],"['RNA binding', 'cadherin binding', 'structural constituent of ribosome']",1,1,0,1,1,1,1,2,4,6
197,TPD52,tumor protein D52 [Source:HGNC Symbol;Acc:HGNC:12005],"['protein homodimerization activity', 'calcium ion binding']",1,0,0,1,0,0,1,1,2,3
198,DLGAP1,DLG associated protein 1 [Source:HGNC Symbol;Acc:HGNC:2905],"['protein binding', 'protein-containing complex binding', 'molecular adaptor activity']",1,1,1,1,1,1,0,3,3,6
199,VCP,valosin containing protein [Source:HGNC Symbol;Acc:HGNC:12666],"['BAT3 complex binding', 'lipid binding', 'ADP binding', 'ubiquitin protein ligase binding', 'protein domain specific binding', 'K48-linked polyubiquitin modification-dependent protein binding', 'identical protein binding', 'deubiquitinase activator activity', 'ATP binding', 'RNA binding', 'MHC class I protein binding', 'ATPase activity', 'ubiquitin-specific protease binding', 'protein phosphatase binding']",1,1,1,1,1,1,1,3,4,7
200,KALRN,kalirin RhoGEF kinase [Source:HGNC Symbol;Acc:HGNC:4814],"['protein serine kinase activity', 'metal ion binding', 'protein threonine kinase activity', 'ATP binding', 'guanyl-nucleotide exchange factor activity']",1,1,0,1,1,1,1,2,4,6
201,PAK2,p21 (RAC1) activated kinase 2 [Source:HGNC Symbol;Acc:HGNC:8591],"['protein serine kinase activity', 'protein tyrosine kinase activator activity', 'cadherin binding', 'protein kinase binding', 'identical protein binding', 'ATP binding', 'protein threonine kinase activity', 'small GTPase binding']",1,0,0,0,0,1,1,1,2,3
202,RGS7,regulator of G protein signaling 7 [Source:HGNC Symbol;Acc:HGNC:10003],"['GTPase activator activity', 'G-protein beta-subunit binding', 'GTPase activity']",1,1,1,1,0,0,1,3,2,5
203,CSNK2B,casein kinase 2 beta [Source:HGNC Symbol;Acc:HGNC:2460],"['transcription factor binding', 'protein domain specific binding', 'protein serine/threonine kinase activity', 'identical protein binding', 'protein kinase regulator activity', 'metal ion binding', 'ribonucleoprotein complex binding', 'chromatin binding', 'signaling receptor binding']",1,1,1,1,0,1,1,3,3,6
204,SRC,"SRC proto-oncogene, non-receptor tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:11283]","['ion channel binding', 'estrogen receptor binding', 'cadherin binding', 'protein kinase C binding', 'ephrin receptor binding', 'ATP binding', 'protein C-terminus binding', 'growth factor receptor binding', 'BMP receptor binding', 'non-membrane spanning protein tyrosine kinase activity', 'insulin receptor binding', 'phosphoprotein binding', 'connexin binding', 'SH2 domain binding', 'ubiquitin protein ligase binding', 'heme binding', 'scaffold protein binding', 'integrin binding', 'ATPase binding']",1,1,0,1,0,1,1,2,3,5
205,ARHGAP44,Rho GTPase activating protein 44 [Source:HGNC Symbol;Acc:HGNC:29096],"['GTPase activator activity', 'small GTPase binding', 'phospholipid binding']",1,0,0,1,1,0,0,1,2,3
206,CNTNAP4,contactin associated protein family member 4 [Source:HGNC Symbol;Acc:HGNC:18747],None,1,0,0,0,0,0,0,1,0,1
207,CPEB1,cytoplasmic polyadenylation element binding protein 1 [Source:HGNC Symbol;Acc:HGNC:21744],"[""mRNA 3'-UTR AU-rich region binding"", 'protein binding', 'ribosome binding', 'translation factor activity, RNA binding', 'metal ion binding', 'translation repressor activity, mRNA regulatory element binding']",1,0,0,0,0,0,0,1,0,1
208,IL1RAPL1,interleukin 1 receptor accessory protein like 1 [Source:HGNC Symbol;Acc:HGNC:5996],"['NAD+ nucleotidase, cyclic ADP-ribose generating', 'NAD(P)+ nucleosidase activity', 'signaling receptor binding']",1,0,0,0,0,0,0,1,0,1
209,PTPRN2,protein tyrosine phosphatase receptor type N2 [Source:HGNC Symbol;Acc:HGNC:9677],['transmembrane receptor protein tyrosine phosphatase activity'],1,0,1,0,0,0,0,2,0,2
210,VCAN,versican [Source:HGNC Symbol;Acc:HGNC:2464],"['hyaluronic acid binding', 'calcium ion binding', 'protein binding', 'extracellular matrix structural constituent conferring compression resistance', 'carbohydrate binding']",1,1,0,1,1,1,1,2,4,6
211,CAMK4,calcium/calmodulin dependent protein kinase IV [Source:HGNC Symbol;Acc:HGNC:1464],"['calmodulin binding', 'calcium-dependent protein serine/threonine kinase activity', 'calmodulin-dependent protein kinase activity', 'ATP binding']",1,0,1,1,1,0,1,2,3,5
212,NPTN,neuroplastin [Source:HGNC Symbol;Acc:HGNC:17867],"['ion channel binding', 'cell-cell adhesion mediator activity', 'type 1 fibroblast growth factor receptor binding']",1,1,1,1,1,1,1,3,4,7
213,CTNND1,catenin delta 1 [Source:HGNC Symbol;Acc:HGNC:2515],"['cadherin binding', 'protein kinase binding', 'signaling receptor binding']",1,1,1,1,1,1,1,3,4,7
214,ACTC1,actin alpha cardiac muscle 1 [Source:HGNC Symbol;Acc:HGNC:143],"['ATPase activity', 'ATP binding', 'myosin binding']",1,0,0,0,0,1,1,1,2,3
215,PAK3,p21 (RAC1) activated kinase 3 [Source:HGNC Symbol;Acc:HGNC:8592],"['SH3 domain binding', 'protein serine kinase activity', 'ATP binding', 'metal ion binding', 'protein threonine kinase activity', 'small GTPase binding', 'MAP kinase kinase activity']",1,0,0,1,0,1,1,1,3,4
216,MAGI3,"membrane associated guanylate kinase, WW and PDZ domain containing 3 [Source:HGNC Symbol;Acc:HGNC:29647]","['guanylate kinase activity', 'protein binding', 'molecular adaptor activity', 'ATP binding']",1,0,0,1,0,0,0,1,1,2
217,RGS14,regulator of G protein signaling 14 [Source:HGNC Symbol;Acc:HGNC:9996],"['G-protein alpha-subunit binding', 'GTPase activator activity', 'protein kinase binding', 'GDP-dissociation inhibitor activity', 'GTPase activating protein binding', 'GTPase activity', 'signaling receptor complex adaptor activity', 'microtubule binding']",1,0,0,1,1,0,0,1,2,3
218,STXBP3,syntaxin binding protein 3 [Source:HGNC Symbol;Acc:HGNC:11446],"['protein-containing complex binding', 'syntaxin-1 binding']",1,1,1,0,0,0,1,3,1,4
219,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D [Source:HGNC Symbol;Acc:HGNC:4588],"['protein binding', 'glutamate-gated calcium ion channel activity', 'NMDA glutamate receptor activity']",1,0,1,0,0,0,0,2,0,2
220,SH3GLB2,"SH3 domain containing GRB2 like, endophilin B2 [Source:HGNC Symbol;Acc:HGNC:10834]","['cadherin binding', 'identical protein binding']",1,1,1,1,1,0,1,3,3,6
221,LIN7A,"lin-7 homolog A, crumbs cell polarity complex component [Source:HGNC Symbol;Acc:HGNC:17787]",['L27 domain binding'],1,1,1,1,0,0,1,3,2,5
222,RPL18,ribosomal protein L18 [Source:HGNC Symbol;Acc:HGNC:10310],"['protein binding', 'RNA binding', 'structural constituent of ribosome']",1,0,0,1,1,1,1,1,4,5
223,CNR1,cannabinoid receptor 1 [Source:HGNC Symbol;Acc:HGNC:2159],"['identical protein binding', 'cannabinoid receptor activity', 'drug binding']",1,0,1,0,0,0,1,2,1,3
224,RAB8A,"RAB8A, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:7007]","['myosin V binding', 'protein kinase binding', 'GDP binding', 'GTPase activity', 'small GTPase binding', 'GTP binding']",1,0,1,1,0,0,1,2,2,4
225,ACTBL2,actin beta like 2 [Source:HGNC Symbol;Acc:HGNC:17780],"['protein kinase binding', 'ATP binding', 'structural constituent of postsynaptic actin cytoskeleton']",1,0,0,1,1,1,1,1,4,5
226,NUMB,NUMB endocytic adaptor protein [Source:HGNC Symbol;Acc:HGNC:8060],"['cadherin binding', 'alpha-catenin binding', 'beta-catenin binding']",1,0,0,1,0,0,0,1,1,2
227,ATP6V1C1,ATPase H+ transporting V1 subunit C1 [Source:HGNC Symbol;Acc:HGNC:856],"['protein binding', 'proton-transporting ATPase activity, rotational mechanism']",1,1,1,1,1,0,1,3,3,6
228,SCRIB,scribble planar cell polarity protein [Source:HGNC Symbol;Acc:HGNC:30377],['cadherin binding'],1,1,0,1,0,1,1,2,3,5
229,RPS5,ribosomal protein S5 [Source:HGNC Symbol;Acc:HGNC:10426],"['protein binding', 'mRNA binding', 'rRNA binding', 'structural constituent of ribosome']",1,0,0,1,1,1,1,1,4,5
230,RPLP0,ribosomal protein lateral stalk subunit P0 [Source:HGNC Symbol;Acc:HGNC:10371],"['protein binding', 'structural constituent of ribosome', 'large ribosomal subunit rRNA binding']",1,1,0,1,1,1,1,2,4,6
231,GABRA5,gamma-aminobutyric acid type A receptor subunit alpha5 [Source:HGNC Symbol;Acc:HGNC:4079],"['GABA-gated chloride ion channel activity', 'inhibitory extracellular ligand-gated ion channel activity', 'transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential', 'GABA receptor binding', 'GABA-A receptor activity', 'benzodiazepine receptor activity']",1,0,1,0,0,0,0,2,0,2
232,CDKL5,cyclin dependent kinase like 5 [Source:HGNC Symbol;Acc:HGNC:11411],"['small GTPase binding', 'cyclin-dependent protein serine/threonine kinase activity', 'ATP binding']",1,0,0,1,1,0,0,1,2,3
233,EIF4G2,eukaryotic translation initiation factor 4 gamma 2 [Source:HGNC Symbol;Acc:HGNC:3297],"['cadherin binding', 'mRNA binding', 'translation initiation factor activity']",1,0,0,1,0,1,1,1,3,4
234,PHB,prohibitin [Source:HGNC Symbol;Acc:HGNC:8912],"['histone deacetylase binding', 'complement component C3b binding', 'complement component C3a binding', 'proteinase activated receptor binding', 'transcription corepressor activity', 'protein heterodimerization activity', 'protein C-terminus binding']",1,1,1,1,1,1,1,3,4,7
235,ITGB4,integrin subunit beta 4 [Source:HGNC Symbol;Acc:HGNC:6158],"['insulin-like growth factor I binding', 'G protein-coupled receptor binding', 'integrin binding', 'neuregulin binding']",1,0,0,0,0,0,0,1,0,1
236,SYT5,synaptotagmin 5 [Source:HGNC Symbol;Acc:HGNC:11513],"['calcium-dependent phospholipid binding', 'calcium ion binding', 'syntaxin binding', 'phosphatidylinositol-4,5-bisphosphate binding', 'clathrin binding', 'phosphatidylserine binding', 'protein heterodimerization activity']",1,1,1,1,1,0,1,3,3,6
237,RPS28,ribosomal protein S28 [Source:HGNC Symbol;Acc:HGNC:10418],"['protein binding', 'RNA binding', 'structural constituent of ribosome']",1,0,0,1,0,0,0,1,1,2
238,CDH9,cadherin 9 [Source:HGNC Symbol;Acc:HGNC:1768],"['cadherin binding', 'calcium ion binding']",1,0,1,1,0,0,0,2,1,3
239,VAMP2,vesicle associated membrane protein 2 [Source:HGNC Symbol;Acc:HGNC:12643],"['calmodulin binding', 'phospholipid binding', 'SNAP receptor activity', 'calcium-dependent protein binding', 'syntaxin-1 binding', 'protein self-association']",1,1,1,1,1,1,1,3,4,7
240,ROR2,receptor tyrosine kinase like orphan receptor 2 [Source:HGNC Symbol;Acc:HGNC:10257],"['coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway', 'Wnt-protein binding', 'mitogen-activated protein kinase kinase kinase binding', 'ATP binding', 'metal ion binding', 'transmembrane receptor protein tyrosine kinase activity']",1,0,0,0,0,0,0,1,0,1
241,MARCKSL1,MARCKS like 1 [Source:HGNC Symbol;Acc:HGNC:7142],"['calmodulin binding', 'actin filament binding']",1,1,1,1,1,1,1,3,4,7
242,SLC3A2,solute carrier family 3 member 2 [Source:HGNC Symbol;Acc:HGNC:11026],"['catalytic activity', 'calcium:sodium antiporter activity', 'cadherin binding', 'double-stranded RNA binding', 'aromatic amino acid transmembrane transporter activity', 'L-leucine transmembrane transporter activity', 'L-alanine transmembrane transporter activity']",1,1,1,1,0,1,1,3,3,6
243,SYT2,synaptotagmin 2 [Source:HGNC Symbol;Acc:HGNC:11510],"['calcium-dependent phospholipid binding', 'calcium ion binding', 'syntaxin binding', 'inositol 1,3,4,5 tetrakisphosphate binding', 'clathrin binding', 'phosphatidylserine binding']",1,1,1,1,1,0,0,3,2,5
244,DGKQ,diacylglycerol kinase theta [Source:HGNC Symbol;Acc:HGNC:2856],"['NAD+ kinase activity', 'activating transcription factor binding', 'diacylglycerol kinase activity', 'kinase binding', 'transmembrane receptor protein tyrosine kinase activator activity', 'ATP binding', 'metal ion binding', 'phospholipase binding']",1,0,0,1,1,0,0,1,2,3
245,HOMER3,homer scaffold protein 3 [Source:HGNC Symbol;Acc:HGNC:17514],"['identical protein binding', 'protein domain specific binding', 'G protein-coupled glutamate receptor binding', 'protein C-terminus binding']",1,0,1,0,0,0,1,2,1,3
246,COMT,catechol-O-methyltransferase [Source:HGNC Symbol;Acc:HGNC:2228],"['catechol O-methyltransferase activity', 'protein binding', 'magnesium ion binding', 'L-dopa O-methyltransferase activity', 'orcinol O-methyltransferase activity']",1,0,0,0,0,0,1,1,1,2
247,RPL26,ribosomal protein L26 [Source:HGNC Symbol;Acc:HGNC:10327],"['protein binding', ""mRNA 5'-UTR binding"", 'structural constituent of ribosome']",1,0,0,1,1,1,1,1,4,5
248,EEF1A2,eukaryotic translation elongation factor 1 alpha 2 [Source:HGNC Symbol;Acc:HGNC:3192],"['GTP binding', 'protein kinase binding', 'GTPase activity', 'translation elongation factor activity']",1,1,1,1,1,1,1,3,4,7
249,SV2B,synaptic vesicle glycoprotein 2B [Source:HGNC Symbol;Acc:HGNC:16874],"['protein binding', 'transmembrane transporter activity']",1,1,1,1,1,0,0,3,2,5
250,KCNQ5,potassium voltage-gated channel subfamily Q member 5 [Source:HGNC Symbol;Acc:HGNC:6299],"['calmodulin binding', 'delayed rectifier potassium channel activity']",1,0,0,1,0,0,0,1,1,2
251,RAB8B,"RAB8B, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:30273]","['TPR domain binding', 'GDP binding', 'GTPase activity', 'GTP binding', 'signaling receptor binding']",1,1,1,1,1,0,1,3,3,6
252,AGRN,agrin [Source:HGNC Symbol;Acc:HGNC:329],"['calcium ion binding', 'dystroglycan binding', 'heparan sulfate proteoglycan binding', 'chondroitin sulfate binding', 'extracellular matrix structural constituent', 'sialic acid binding', 'laminin binding', 'structural constituent of cytoskeleton']",1,1,1,0,0,0,1,3,1,4
253,LRRTM2,leucine rich repeat transmembrane neuronal 2 [Source:HGNC Symbol;Acc:HGNC:19409],['neurexin family protein binding'],1,0,0,0,0,0,0,1,0,1
254,MTOR,mechanistic target of rapamycin kinase [Source:HGNC Symbol;Acc:HGNC:3942],"['TFIIIC-class transcription factor complex binding', 'protein serine kinase activity', 'RNA polymerase III type 3 promoter sequence-specific DNA binding', 'protein domain specific binding', 'RNA polymerase III type 1 promoter sequence-specific DNA binding', 'protein kinase binding', 'ribosome binding', 'identical protein binding', 'RNA polymerase III type 2 promoter sequence-specific DNA binding', 'ATP binding', 'protein threonine kinase activity', 'phosphoprotein binding']",1,0,0,1,0,0,1,1,2,3
255,APBA1,amyloid beta precursor protein binding family A member 1 [Source:HGNC Symbol;Acc:HGNC:578],"['amyloid-beta binding', 'protein binding']",1,0,1,1,1,0,1,2,3,5
256,CPSF2,cleavage and polyadenylation specific factor 2 [Source:HGNC Symbol;Acc:HGNC:2325],"['protein binding', 'RNA binding']",1,0,0,0,0,0,1,1,1,2
257,NRCAM,neuronal cell adhesion molecule [Source:HGNC Symbol;Acc:HGNC:7994],"['ankyrin binding', 'protein binding involved in heterotypic cell-cell adhesion']",1,1,0,1,1,1,1,2,4,6
258,ARPC5L,actin related protein 2/3 complex subunit 5 like [Source:HGNC Symbol;Acc:HGNC:23366],['actin filament binding'],1,1,0,1,1,0,0,2,2,4
259,YWHAG,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma [Source:HGNC Symbol;Acc:HGNC:12852],"['protein domain specific binding', 'protein kinase C binding', 'protein kinase C inhibitor activity', 'insulin-like growth factor receptor binding', 'identical protein binding', 'RNA binding', 'receptor tyrosine kinase binding']",1,1,1,1,1,1,1,3,4,7
260,CNTNAP1,contactin associated protein 1 [Source:HGNC Symbol;Acc:HGNC:8011],"['SH3 domain binding', 'signaling receptor activity']",1,1,1,1,1,0,1,3,3,6
261,NRG1,neuregulin 1 [Source:HGNC Symbol;Acc:HGNC:7997],"['cytokine activity', 'ErbB-2 class receptor binding', 'ErbB-3 class receptor binding', 'integrin binding', 'transmembrane receptor protein tyrosine kinase activator activity', 'growth factor activity', 'chemorepellent activity', 'receptor tyrosine kinase binding', 'transcription coregulator activity']",1,0,1,0,0,0,0,2,0,2
262,PTPRD,protein tyrosine phosphatase receptor type D [Source:HGNC Symbol;Acc:HGNC:9668],"['cell adhesion molecule binding', 'transmembrane receptor protein tyrosine phosphatase activity', 'signaling receptor binding']",1,1,0,1,1,1,1,2,4,6
263,SGIP1,SH3GL interacting endocytic adaptor 1 [Source:HGNC Symbol;Acc:HGNC:25412],"['microtubule binding', 'phospholipid binding', 'SH3 domain binding']",1,1,0,1,1,0,1,2,3,5
264,AAK1,AP2 associated kinase 1 [Source:HGNC Symbol;Acc:HGNC:19679],"['protein serine kinase activity', 'protein threonine kinase activity', 'ATP binding', 'AP-2 adaptor complex binding', 'Notch binding']",1,1,1,1,1,1,1,3,4,7
265,SLC6A1,solute carrier family 6 member 1 [Source:HGNC Symbol;Acc:HGNC:11042],"['sodium:chloride symporter activity', 'gamma-aminobutyric acid:sodium symporter activity', 'identical protein binding', 'neurotransmitter binding', 'metal ion binding']",1,1,1,0,0,0,0,3,0,3
266,PPFIA4,PTPRF interacting protein alpha 4 [Source:HGNC Symbol;Acc:HGNC:9248],['protein binding'],1,1,1,0,0,0,0,3,0,3
267,SYNJ1,synaptojanin 1 [Source:HGNC Symbol;Acc:HGNC:11503],"['phosphatidylinositol-3-phosphatase activity', 'SH3 domain binding', 'phosphatidylinositol-4-phosphate phosphatase activity', 'phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity', 'RNA binding']",1,1,1,1,1,0,1,3,3,6
268,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A [Source:HGNC Symbol;Acc:HGNC:16767],"['transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential', 'identical protein binding', 'glycine binding', 'calcium channel activity', 'protein phosphatase 2A binding', 'NMDA glutamate receptor activity']",1,0,0,0,0,0,0,1,0,1
269,RPL34,ribosomal protein L34 [Source:HGNC Symbol;Acc:HGNC:10340],"['RNA binding', 'cadherin binding', 'structural constituent of ribosome']",1,0,0,1,1,0,1,1,3,4
270,APOE,apolipoprotein E [Source:HGNC Symbol;Acc:HGNC:613],"['phosphatidylcholine-sterol O-acyltransferase activator activity', 'phospholipid binding', 'heparan sulfate proteoglycan binding', 'metal chelating activity', 'lipoprotein particle binding', 'low-density lipoprotein particle receptor binding', 'heparin binding', 'protein homodimerization activity', 'antioxidant activity', 'structural molecule activity', 'amyloid-beta binding', 'tau protein binding', 'cholesterol transfer activity', 'very-low-density lipoprotein particle receptor binding']",1,1,1,0,0,0,1,3,1,4
271,MARK2,microtubule affinity regulating kinase 2 [Source:HGNC Symbol;Acc:HGNC:3332],"['protein kinase activator activity', 'protein serine kinase activity', 'lipid binding', 'cadherin binding', 'magnesium ion binding', 'ATP binding', 'tau-protein kinase activity', 'protein threonine kinase activity', 'RNA binding', 'tau protein binding']",1,1,0,1,1,1,1,2,4,6
272,DCC,DCC netrin 1 receptor [Source:HGNC Symbol;Acc:HGNC:2701],"['protein binding', 'netrin receptor activity']",1,0,0,0,0,1,0,1,1,2
273,ATP8A1,ATPase phospholipid transporting 8A1 [Source:HGNC Symbol;Acc:HGNC:13531],"['ATPase-coupled cation transmembrane transporter activity', 'protein binding', 'magnesium ion binding', 'phosphatidylserine flippase activity', 'ATP binding', 'ATPase activity']",1,1,1,1,0,0,1,3,2,5
274,SLC6A3,solute carrier family 6 member 3 [Source:HGNC Symbol;Acc:HGNC:11049],"['dopamine:sodium symporter activity', 'norepinephrine:sodium symporter activity', 'protein N-terminus binding', 'dopamine binding', 'metal ion binding', 'protein phosphatase 2A binding', 'protein-containing complex binding', 'protease binding', 'neurotransmitter transmembrane transporter activity', 'drug binding', 'signaling receptor binding']",1,0,1,0,1,0,0,2,1,3
275,ACTN2,actinin alpha 2 [Source:HGNC Symbol;Acc:HGNC:164],"['ion channel binding', 'LIM domain binding', 'calcium ion binding', 'structural constituent of muscle', 'titin Z domain binding', 'phosphatidylinositol-4,5-bisphosphate binding', 'titin binding', 'FATZ binding', 'integrin binding', 'identical protein binding', 'actin filament binding', 'thyroid hormone receptor coactivator activity']",1,1,0,1,1,1,0,2,3,5
276,RAB35,"RAB35, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9774]","['protein binding', 'phosphatidylinositol-4,5-bisphosphate binding', 'GDP binding', 'GTPase activity', 'GTP binding']",1,1,1,1,1,1,1,3,4,7
277,MPP2,membrane palmitoylated protein 2 [Source:HGNC Symbol;Acc:HGNC:7220],['protein binding'],1,1,1,1,1,0,1,3,3,6
278,TRIM9,tripartite motif containing 9 [Source:HGNC Symbol;Acc:HGNC:16288],"['zinc ion binding', 'SNARE binding', 'protein domain specific binding', 'protein homodimerization activity', 'ubiquitin protein ligase activity']",1,1,0,1,0,1,0,2,2,4
279,ABI1,abl interactor 1 [Source:HGNC Symbol;Acc:HGNC:11320],"['SH3 domain binding', 'cadherin binding', 'cytoskeletal protein binding', 'protein tyrosine kinase activator activity']",1,1,1,1,1,1,1,3,4,7
280,DPYSL3,dihydropyrimidinase like 3 [Source:HGNC Symbol;Acc:HGNC:3015],"['SH3 domain binding', 'chondroitin sulfate binding', 'filamin binding', 'identical protein binding']",1,1,1,1,1,1,1,3,4,7
281,TACC3,transforming acidic coiled-coil containing protein 3 [Source:HGNC Symbol;Acc:HGNC:11524],['protein binding'],1,0,0,0,0,0,0,1,0,1
282,ABHD17B,"abhydrolase domain containing 17B, depalmitoylase [Source:HGNC Symbol;Acc:HGNC:24278]",['palmitoyl-(protein) hydrolase activity'],1,0,0,0,0,0,0,1,0,1
283,CACNA1D,calcium voltage-gated channel subunit alpha1 D [Source:HGNC Symbol;Acc:HGNC:1391],"['ankyrin binding', 'high voltage-gated calcium channel activity', 'voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels', 'alpha-actinin binding', 'metal ion binding', 'voltage-gated calcium channel activity involved SA node cell action potential']",1,0,1,1,0,0,0,2,1,3
284,SYNE1,spectrin repeat containing nuclear envelope protein 1 [Source:HGNC Symbol;Acc:HGNC:17089],"['lamin binding', 'enzyme binding', 'protein homodimerization activity', 'actin filament binding', 'RNA binding', 'cytoskeleton-nuclear membrane anchor activity']",1,1,0,1,0,0,1,2,2,4
285,CAMKV,CaM kinase like vesicle associated [Source:HGNC Symbol;Acc:HGNC:28788],"['calmodulin binding', 'calmodulin-dependent protein kinase activity', 'ATP binding']",1,1,0,1,1,1,1,2,4,6
286,DLG5,discs large MAGUK scaffold protein 5 [Source:HGNC Symbol;Acc:HGNC:2904],"['signaling receptor complex adaptor activity', 'cytoskeletal protein binding', 'beta-catenin binding']",1,0,0,0,0,1,1,1,2,3
287,GRIA3,glutamate ionotropic receptor AMPA type subunit 3 [Source:HGNC Symbol;Acc:HGNC:4573],"['amyloid-beta binding', 'AMPA glutamate receptor activity']",1,0,1,1,1,1,0,2,3,5
288,GABRA4,gamma-aminobutyric acid type A receptor subunit alpha4 [Source:HGNC Symbol;Acc:HGNC:4078],"['GABA-gated chloride ion channel activity', 'inhibitory extracellular ligand-gated ion channel activity', 'transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential', 'GABA-A receptor activity', 'benzodiazepine receptor activity']",1,1,1,1,1,0,0,3,2,5
289,DACT1,dishevelled binding antagonist of beta catenin 1 [Source:HGNC Symbol;Acc:HGNC:17748],"['histone deacetylase binding', 'protein kinase A binding', 'RNA polymerase II transcription factor binding', 'protein kinase C binding', 'delta-catenin binding', 'beta-catenin binding']",1,0,0,0,0,0,0,1,0,1
290,CACNA1H,calcium voltage-gated channel subunit alpha1 H [Source:HGNC Symbol;Acc:HGNC:1395],"['voltage-gated sodium channel activity', 'metal ion binding', 'scaffold protein binding', 'low voltage-gated calcium channel activity']",1,0,0,0,0,0,0,1,0,1
291,SLC6A8,solute carrier family 6 member 8 [Source:HGNC Symbol;Acc:HGNC:11055],['creatine:sodium symporter activity'],1,0,1,0,0,0,0,2,0,2
292,LRRC4B,leucine rich repeat containing 4B [Source:HGNC Symbol;Acc:HGNC:25042],['signaling receptor binding'],1,0,0,1,1,0,0,1,2,3
293,ATP6V1G1,ATPase H+ transporting V1 subunit G1 [Source:HGNC Symbol;Acc:HGNC:864],"['ATPase binding', 'ATPase activity']",1,1,0,1,0,0,0,2,1,3
294,RPS15,ribosomal protein S15 [Source:HGNC Symbol;Acc:HGNC:10388],"['protein binding', 'DNA binding', 'structural constituent of ribosome', 'RNA binding']",1,1,0,1,1,0,0,2,2,4
295,SLC10A4,solute carrier family 10 member 4 [Source:HGNC Symbol;Acc:HGNC:22980],"['protein binding', 'bile acid:sodium symporter activity']",1,0,0,0,0,0,0,1,0,1
296,NTNG1,netrin G1 [Source:HGNC Symbol;Acc:HGNC:23319],['cell-cell adhesion mediator activity'],1,0,0,0,0,0,1,1,1,2
297,RPS17,ribosomal protein S17 [Source:HGNC Symbol;Acc:HGNC:10397],"['RNA binding', 'structural constituent of ribosome']",1,1,0,1,1,0,1,2,3,5
298,EXOC4,exocyst complex component 4 [Source:HGNC Symbol;Acc:HGNC:30389],"['small GTPase binding', 'PDZ domain binding', 'protein N-terminus binding']",1,1,1,1,1,1,1,3,4,7
299,CDK5,cyclin dependent kinase 5 [Source:HGNC Symbol;Acc:HGNC:1774],"['ErbB-2 class receptor binding', 'cyclin-dependent protein serine/threonine kinase activity', 'p53 binding', 'protein serine kinase activity', 'protein kinase binding', 'acetylcholine receptor activator activity', 'ErbB-3 class receptor binding', 'ephrin receptor binding', 'voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels', 'Hsp90 protein binding', 'ATP binding', 'tau-protein kinase activity', 'protein threonine kinase activity', 'tau protein binding']",1,1,0,1,1,1,1,2,4,6
300,ITGA3,integrin subunit alpha 3 [Source:HGNC Symbol;Acc:HGNC:6139],"['protein domain specific binding', 'fibronectin binding', 'integrin binding', 'metal ion binding', 'protein heterodimerization activity', 'protease binding', 'laminin binding', 'collagen binding']",1,0,0,0,0,0,0,1,0,1
301,CAMK1,calcium/calmodulin dependent protein kinase I [Source:HGNC Symbol;Acc:HGNC:1459],"['calmodulin binding', 'calmodulin-dependent protein kinase activity', 'ATP binding']",1,0,1,0,0,0,0,2,0,2
302,CNTN1,contactin 1 [Source:HGNC Symbol;Acc:HGNC:2171],"['protein binding', 'carbohydrate binding']",1,1,1,1,1,1,1,3,4,7
303,GABRA3,gamma-aminobutyric acid type A receptor subunit alpha3 [Source:HGNC Symbol;Acc:HGNC:4077],"['GABA-gated chloride ion channel activity', 'inhibitory extracellular ligand-gated ion channel activity', 'protein binding', 'transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential', 'GABA-A receptor activity', 'benzodiazepine receptor activity']",1,0,1,1,0,1,1,2,3,5
304,ADAM22,ADAM metallopeptidase domain 22 [Source:HGNC Symbol;Acc:HGNC:201],"['integrin binding', 'metalloendopeptidase activity']",1,1,1,1,1,0,1,3,3,6
305,ANXA1,annexin A1 [Source:HGNC Symbol;Acc:HGNC:533],"['calcium-dependent phospholipid binding', 'double-stranded DNA helicase activity', 'calcium ion binding', 'single-stranded DNA binding', 'cadherin binding involved in cell-cell adhesion', 'calcium-dependent protein binding', 'DNA/DNA annealing activity', 'identical protein binding', 'phospholipase A2 inhibitor activity', 'single-stranded RNA binding', 'signaling receptor binding']",1,1,1,0,0,1,1,3,2,5
306,ADAM23,ADAM metallopeptidase domain 23 [Source:HGNC Symbol;Acc:HGNC:202],"['integrin binding', 'metalloendopeptidase activity']",1,1,1,1,1,0,0,3,2,5
307,CACNB4,calcium voltage-gated channel auxiliary subunit beta 4 [Source:HGNC Symbol;Acc:HGNC:1404],"['protein binding', 'high voltage-gated calcium channel activity']",1,1,1,1,1,0,0,3,2,5
308,HTR7,5-hydroxytryptamine receptor 7 [Source:HGNC Symbol;Acc:HGNC:5302],"['protein binding', 'neurotransmitter receptor activity', 'G protein-coupled serotonin receptor activity']",1,0,1,0,0,0,0,2,0,2
309,CDH23,cadherin related 23 [Source:HGNC Symbol;Acc:HGNC:13733],"['cadherin binding', 'calcium ion binding']",1,0,1,0,0,0,0,2,0,2
310,PPP2CA,protein phosphatase 2 catalytic subunit alpha [Source:HGNC Symbol;Acc:HGNC:9299],"['protein serine phosphatase activity', 'GABA receptor binding', 'metal ion binding', 'protein threonine phosphatase activity', 'tau protein binding', 'protein heterodimerization activity', 'protein C-terminus binding']",1,1,0,0,1,0,1,2,2,4
311,SYNJ2,synaptojanin 2 [Source:HGNC Symbol;Acc:HGNC:11504],"['RNA binding', 'phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity', 'SH3 domain binding']",1,1,1,0,0,0,0,3,0,3
312,PCBP2,poly(rC) binding protein 2 [Source:HGNC Symbol;Acc:HGNC:8648],"['ubiquitin protein ligase binding', 'mRNA binding', 'C-rich single-stranded DNA binding']",1,1,0,1,1,1,1,2,4,6
313,DAG1,dystroglycan 1 [Source:HGNC Symbol;Acc:HGNC:2666],"['SH2 domain binding', 'calcium ion binding', 'dystroglycan binding', 'virus receptor activity', 'structural constituent of muscle', 'laminin-1 binding', 'actin binding', 'tubulin binding', 'alpha-actinin binding', 'vinculin binding']",1,0,0,0,0,0,0,1,0,1
314,PAK1,p21 (RAC1) activated kinase 1 [Source:HGNC Symbol;Acc:HGNC:8590],"['protein serine kinase activity', 'protein kinase binding', 'ATP binding', 'protein threonine kinase activity', 'small GTPase binding', 'collagen binding']",1,1,0,1,0,1,1,2,3,5
315,GABRB2,gamma-aminobutyric acid type A receptor subunit beta2 [Source:HGNC Symbol;Acc:HGNC:4082],"['GABA-gated chloride ion channel activity', 'transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential', 'GABA-A receptor activity', 'inhibitory extracellular ligand-gated ion channel activity']",1,0,1,1,0,0,0,2,1,3
316,NTRK2,neurotrophic receptor tyrosine kinase 2 [Source:HGNC Symbol;Acc:HGNC:8032],"['brain-derived neurotrophic factor binding', 'brain-derived neurotrophic factor-activated receptor activity', 'protein homodimerization activity', 'ATP binding', 'protease binding']",1,1,1,1,0,0,1,3,2,5
317,NAPA,NSF attachment protein alpha [Source:HGNC Symbol;Acc:HGNC:7641],"['protein-containing complex binding', 'soluble NSF attachment protein activity', 'syntaxin binding']",1,1,1,1,0,1,1,3,3,6
318,ADCY8,adenylate cyclase 8 [Source:HGNC Symbol;Acc:HGNC:239],"['calmodulin binding', 'actin binding', 'calcium- and calmodulin-responsive adenylate cyclase activity', 'protein homodimerization activity', 'ATP binding', 'metal ion binding', 'protein phosphatase 2A binding', 'protein heterodimerization activity']",1,0,1,1,0,0,0,2,1,3
319,MYO9A,myosin IXA [Source:HGNC Symbol;Acc:HGNC:7608],"['GTPase activator activity', 'actin binding', 'motor activity', 'ATP binding', 'metal ion binding']",1,0,0,1,1,0,1,1,3,4
320,KCNJ6,potassium inwardly rectifying channel subfamily J member 6 [Source:HGNC Symbol;Acc:HGNC:6267],"['protein binding', 'G-protein activated inward rectifier potassium channel activity']",1,0,1,0,0,0,0,2,0,2
321,PFN2,profilin 2 [Source:HGNC Symbol;Acc:HGNC:8882],"['actin monomer binding', 'phosphatidylinositol-4,5-bisphosphate binding', 'ATPase activity']",1,1,1,1,1,1,1,3,4,7
322,ITGB3,integrin subunit beta 3 [Source:HGNC Symbol;Acc:HGNC:6156],"['virus receptor activity', 'fibroblast growth factor binding', 'platelet-derived growth factor receptor binding', 'fibrinogen binding', 'neuregulin binding', 'fibronectin binding', 'vascular endothelial growth factor receptor 2 binding', 'insulin-like growth factor I binding', 'integrin binding', 'identical protein binding', 'extracellular matrix binding', 'coreceptor activity', 'protein disulfide isomerase activity', 'C-X3-C chemokine binding', 'protease binding']",1,0,0,0,0,0,0,1,0,1
323,GRID1,glutamate ionotropic receptor delta type subunit 1 [Source:HGNC Symbol;Acc:HGNC:4575],"['ionotropic glutamate receptor activity', 'transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential']",1,0,0,0,0,0,1,1,1,2
324,HNRNPAB,heterogeneous nuclear ribonucleoprotein A/B [Source:HGNC Symbol;Acc:HGNC:5034],"['protein binding', 'mRNA binding']",1,0,0,0,0,1,1,1,2,3
325,EPN1,epsin 1 [Source:HGNC Symbol;Acc:HGNC:21604],"['clathrin binding', 'phospholipid binding']",1,0,0,1,0,1,1,1,3,4
326,ITPR3,"inositol 1,4,5-trisphosphate receptor type 3 [Source:HGNC Symbol;Acc:HGNC:6182]","['calcium ion binding', 'inositol 1,3,4,5 tetrakisphosphate binding', 'protein binding', 'phosphatidylinositol binding', 'inositol hexakisphosphate binding', 'inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity', 'inositol 1,4,5 trisphosphate binding']",1,0,0,1,0,0,0,1,1,2
327,HAP1,huntingtin associated protein 1 [Source:HGNC Symbol;Acc:HGNC:4812],"['ion channel binding', 'brain-derived neurotrophic factor binding', 'myosin binding', 'signaling receptor binding']",1,0,0,0,1,0,0,1,1,2
328,NSF,"N-ethylmaleimide sensitive factor, vesicle fusing ATPase [Source:HGNC Symbol;Acc:HGNC:8016]","['metal ion binding', 'protein kinase binding', 'protein-containing complex binding', 'syntaxin-1 binding', 'ATP binding', 'small GTPase binding', 'PDZ domain binding', 'ATPase activity', 'ionotropic glutamate receptor binding']",1,1,1,1,1,1,1,3,4,7
329,EFNB3,ephrin B3 [Source:HGNC Symbol;Acc:HGNC:3228],"['ephrin receptor binding', 'transmembrane-ephrin receptor activity', 'virus receptor activity']",1,0,0,1,0,0,0,1,1,2
330,STXBP5,syntaxin binding protein 5 [Source:HGNC Symbol;Acc:HGNC:19665],"['GTPase activator activity', 'small GTPase binding', 'myosin II binding', 'syntaxin-1 binding']",1,1,1,1,1,1,1,3,4,7
331,DROSHA,drosha ribonuclease III [Source:HGNC Symbol;Acc:HGNC:17904],"['DEAD/H-box RNA helicase binding', 'primary miRNA binding', 'ribonuclease III activity', 'double-stranded RNA binding', 'lipopolysaccharide binding', 'protein homodimerization activity', 'metal ion binding', 'R-SMAD binding']",1,0,0,0,0,0,0,1,0,1
332,DBN1,drebrin 1 [Source:HGNC Symbol;Acc:HGNC:2695],"['cadherin binding', 'actin filament binding', 'profilin binding']",1,1,1,1,1,1,1,3,4,7
333,SH3GL1,"SH3 domain containing GRB2 like 1, endophilin A2 [Source:HGNC Symbol;Acc:HGNC:10830]","['ion channel binding', 'SH3 domain binding', 'beta-1 adrenergic receptor binding', 'lipid binding', 'GTPase binding', 'cadherin binding', 'phosphatase binding', 'identical protein binding', 'protein C-terminus binding']",1,1,0,1,1,0,1,2,3,5
334,FRMPD4,FERM and PDZ domain containing 4 [Source:HGNC Symbol;Acc:HGNC:29007],"['protein binding', 'phosphatidylinositol-4,5-bisphosphate binding']",1,0,1,0,0,0,0,2,0,2
335,SLC6A5,solute carrier family 6 member 5 [Source:HGNC Symbol;Acc:HGNC:11051],"['glycine:sodium symporter activity', 'metal ion binding']",1,0,1,0,0,0,0,2,0,2
336,CACNG2,calcium voltage-gated channel auxiliary subunit gamma 2 [Source:HGNC Symbol;Acc:HGNC:1406],"['channel regulator activity', 'voltage-gated calcium channel activity', 'ionotropic glutamate receptor binding']",1,0,1,1,0,0,0,2,1,3
337,PTPRS,protein tyrosine phosphatase receptor type S [Source:HGNC Symbol;Acc:HGNC:9681],"['heparin binding', 'chondroitin sulfate binding', 'heparan sulfate proteoglycan binding', 'protein tyrosine phosphatase activity']",1,1,1,1,1,1,1,3,4,7
338,GLRA4,glycine receptor alpha 4 (pseudogene) [Source:HGNC Symbol;Acc:HGNC:31715],"['transmitter-gated ion channel activity', 'glycine binding', 'transmembrane signaling receptor activity', 'chloride channel activity']",1,0,0,0,0,0,0,1,0,1
339,RPS6KB1,ribosomal protein S6 kinase B1 [Source:HGNC Symbol;Acc:HGNC:10436],"['protein serine kinase activity', 'protein binding', 'ribosomal protein S6 kinase activity', 'protein serine/threonine/tyrosine kinase activity', 'ATP binding', 'protein threonine kinase activity']",1,1,0,0,0,0,0,2,0,2
340,ABI2,abl interactor 2 [Source:HGNC Symbol;Acc:HGNC:24011],"['SH3 domain binding', 'proline-rich region binding', 'ubiquitin protein ligase binding', 'DNA binding', 'cytoskeletal anchor activity', 'identical protein binding', 'kinase binding', 'small GTPase binding']",1,1,1,1,1,1,1,3,4,7
341,SLC6A6,solute carrier family 6 member 6 [Source:HGNC Symbol;Acc:HGNC:11052],"['gamma-aminobutyric acid transmembrane transporter activity', 'alanine transmembrane transporter activity', 'taurine:sodium symporter activity']",1,0,1,0,0,0,0,2,0,2
342,ATP6V0D1,ATPase H+ transporting V0 subunit d1 [Source:HGNC Symbol;Acc:HGNC:13724],"['protein binding', 'protein-containing complex binding', 'proton-transporting ATPase activity, rotational mechanism']",1,1,1,1,1,1,1,3,4,7
343,RGS9,regulator of G protein signaling 9 [Source:HGNC Symbol;Acc:HGNC:10004],"['GTPase activator activity', 'GTPase activity']",1,0,0,1,1,0,0,1,2,3
344,CRIPT,CXXC repeat containing interactor of PDZ3 domain [Source:HGNC Symbol;Acc:HGNC:14312],"['protein-containing complex binding', 'microtubule binding', 'PDZ domain binding', 'scaffold protein binding']",1,1,0,0,0,0,0,2,0,2
345,CRTC1,CREB regulated transcription coactivator 1 [Source:HGNC Symbol;Acc:HGNC:16062],['cAMP response element binding protein binding'],1,0,0,0,0,0,0,1,0,1
346,LRFN4,leucine rich repeat and fibronectin type III domain containing 4 [Source:HGNC Symbol;Acc:HGNC:28456],['protein binding'],1,0,0,0,0,0,0,1,0,1
347,SNAP23,synaptosome associated protein 23 [Source:HGNC Symbol;Acc:HGNC:11131],"['SNAP receptor activity', 'syntaxin binding']",1,0,1,1,0,0,0,2,1,3
348,RAPSN,receptor associated protein of the synapse [Source:HGNC Symbol;Acc:HGNC:9863],"['acetylcholine receptor binding', 'protein-membrane adaptor activity', 'metal ion binding']",1,0,0,0,0,0,0,1,0,1
349,TANC1,"tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 [Source:HGNC Symbol;Acc:HGNC:29364]",['protein binding'],1,0,0,0,0,0,0,1,0,1
350,RPL24,ribosomal protein L24 [Source:HGNC Symbol;Acc:HGNC:10325],"['RNA binding', 'cadherin binding', 'structural constituent of ribosome']",1,1,0,1,0,1,1,2,3,5
351,LPAR1,lysophosphatidic acid receptor 1 [Source:HGNC Symbol;Acc:HGNC:3166],"['lysophosphatidic acid receptor activity', 'PDZ domain binding', 'G-protein alpha-subunit binding', 'lysophosphatidic acid binding']",1,0,0,0,0,0,0,1,0,1
352,RAPGEF4,Rap guanine nucleotide exchange factor 4 [Source:HGNC Symbol;Acc:HGNC:16626],"['guanyl-nucleotide exchange factor activity', 'small GTPase binding', 'cAMP binding']",1,1,1,1,1,0,1,3,3,6
353,ADAM10,ADAM metallopeptidase domain 10 [Source:HGNC Symbol;Acc:HGNC:188],"['SH3 domain binding', 'protein kinase binding', 'metalloendopeptidase activity involved in amyloid precursor protein catabolic process', 'protein homodimerization activity', 'integrin binding', 'metal ion binding']",1,0,0,0,0,0,1,1,1,2
354,SLC32A1,solute carrier family 32 member 1 [Source:HGNC Symbol;Acc:HGNC:11018],"['gamma-aminobutyric acid:proton symporter activity', 'glycine transmembrane transporter activity']",1,1,1,1,1,0,0,3,2,5
355,OPRM1,opioid receptor mu 1 [Source:HGNC Symbol;Acc:HGNC:8156],"['G-protein alpha-subunit binding', 'protein domain specific binding', 'voltage-gated calcium channel activity', 'G-protein beta-subunit binding', 'morphine receptor activity', 'filamin binding', 'neuropeptide binding', 'beta-endorphin receptor activity', 'protein C-terminus binding']",1,0,1,0,0,0,0,2,0,2
356,YWHAE,tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon [Source:HGNC Symbol;Acc:HGNC:12851],"['histone deacetylase binding', 'ion channel binding', 'ubiquitin protein ligase binding', 'protein domain specific binding', 'cadherin binding', 'scaffold protein binding', 'RNA binding', 'MHC class II protein complex binding', 'identical protein binding', 'phosphoserine residue binding', 'potassium channel regulator activity', 'protein heterodimerization activity', 'calcium channel regulator activity', 'protein phosphatase binding']",1,1,1,1,1,1,1,3,4,7
357,ATP6V0C,ATPase H+ transporting V0 subunit c [Source:HGNC Symbol;Acc:HGNC:855],"['proton-transporting ATP synthase activity, rotational mechanism', 'ubiquitin protein ligase binding', 'proton-transporting ATPase activity, rotational mechanism']",1,1,1,0,0,0,0,3,0,3
358,STX2,syntaxin 2 [Source:HGNC Symbol;Acc:HGNC:3403],"['calcium-dependent protein binding', 'SNARE binding', 'SNAP receptor activity', 'structural molecule activity']",1,0,1,0,0,0,0,2,0,2
359,CLCN3,chloride voltage-gated channel 3 [Source:HGNC Symbol;Acc:HGNC:2021],"['voltage-gated chloride channel activity', 'volume-sensitive chloride channel activity', 'solute:proton antiporter activity', 'ATP binding', 'PDZ domain binding']",1,1,0,0,0,0,1,2,1,3
360,SYT11,synaptotagmin 11 [Source:HGNC Symbol;Acc:HGNC:19239],"['calcium-dependent phospholipid binding', 'SNARE binding', 'calcium ion binding', 'beta-tubulin binding', 'ubiquitin protein ligase binding', 'clathrin binding', 'translation initiation factor binding', 'phosphatidylserine binding', 'identical protein binding']",1,0,0,1,0,1,1,1,3,4
361,DLG4,discs large MAGUK scaffold protein 4 [Source:HGNC Symbol;Acc:HGNC:2903],"['beta-1 adrenergic receptor binding', 'neuroligin family protein binding', 'P2Y1 nucleotide receptor binding', 'acetylcholine receptor binding', 'scaffold protein binding', 'D1 dopamine receptor binding', 'kinase binding', 'ionotropic glutamate receptor binding', 'protein-containing complex binding', 'PDZ domain binding', 'protein C-terminus binding', 'protein phosphatase binding']",1,1,1,1,1,0,1,3,3,6
362,FZD5,frizzled class receptor 5 [Source:HGNC Symbol;Acc:HGNC:4043],"['Wnt-protein binding', 'lipid binding', 'Wnt-activated receptor activity', 'ubiquitin protein ligase binding', 'protein kinase binding', 'G protein-coupled receptor activity', 'amyloid-beta binding', 'protein-containing complex binding']",1,0,0,0,0,0,0,1,0,1
363,ATAD1,ATPase family AAA domain containing 1 [Source:HGNC Symbol;Acc:HGNC:25903],"['ATPase activity', 'ATP binding']",1,1,0,1,1,0,1,2,3,5
364,VAMP3,vesicle associated membrane protein 3 [Source:HGNC Symbol;Acc:HGNC:12644],"['SNAP receptor activity', 'syntaxin-1 binding']",1,1,1,1,1,0,0,3,2,5
365,ARHGAP39,Rho GTPase activating protein 39 [Source:HGNC Symbol;Acc:HGNC:29351],['GTPase activator activity'],1,0,0,1,0,1,1,1,3,4
366,SYDE2,synapse defective Rho GTPase homolog 2 [Source:HGNC Symbol;Acc:HGNC:25841],['GTPase activator activity'],1,0,0,0,0,0,0,1,0,1
367,KCNC2,potassium voltage-gated channel subfamily C member 2 [Source:HGNC Symbol;Acc:HGNC:6234],"['ion channel binding', 'delayed rectifier potassium channel activity', 'voltage-gated ion channel activity involved in regulation of presynaptic membrane potential']",1,0,1,0,0,0,0,2,0,2
368,RPS20,ribosomal protein S20 [Source:HGNC Symbol;Acc:HGNC:10405],"['protein binding', 'RNA binding', 'structural constituent of ribosome']",1,0,0,1,1,1,1,1,4,5
369,ADD3,adducin 3 [Source:HGNC Symbol;Acc:HGNC:245],"['calmodulin binding', 'actin filament binding', 'structural constituent of cytoskeleton', 'spectrin binding']",1,1,1,1,1,0,1,3,3,6
370,SLC16A1,solute carrier family 16 member 1 [Source:HGNC Symbol;Acc:HGNC:10922],"['organic cyclic compound binding', 'mevalonate transmembrane transporter activity', 'symporter activity', 'identical protein binding', 'lactate transmembrane transporter activity']",1,0,0,0,0,0,1,1,1,2
371,RPL27,ribosomal protein L27 [Source:HGNC Symbol;Acc:HGNC:10328],"['protein binding', 'RNA binding', 'structural constituent of ribosome']",1,1,0,1,1,1,1,2,4,6
372,NCAN,neurocan [Source:HGNC Symbol;Acc:HGNC:2465],"['hyaluronic acid binding', 'calcium ion binding', 'carbohydrate binding']",1,0,1,1,1,1,0,2,3,5
373,FGG,fibrinogen gamma chain [Source:HGNC Symbol;Acc:HGNC:3694],"['extracellular matrix structural constituent', 'signaling receptor binding', 'identical protein binding', 'metal ion binding', 'cell adhesion molecule binding']",1,1,0,0,0,0,0,2,0,2
374,KCNC1,potassium voltage-gated channel subfamily C member 1 [Source:HGNC Symbol;Acc:HGNC:6233],"['ion channel binding', 'delayed rectifier potassium channel activity', 'kinesin binding', 'voltage-gated ion channel activity involved in regulation of presynaptic membrane potential']",1,0,1,0,0,0,0,2,0,2
375,AKR1A1,aldo-keto reductase family 1 member A1 [Source:HGNC Symbol;Acc:HGNC:380],"['glucuronolactone reductase activity', 'protein binding', 'alditol:NADP+ 1-oxidoreductase activity', 'L-glucuronate reductase activity', 'electron transfer activity', 'allyl-alcohol dehydrogenase activity']",1,1,0,0,0,1,1,2,2,4
376,CLU,clusterin [Source:HGNC Symbol;Acc:HGNC:2095],"['chaperone binding', 'ubiquitin protein ligase binding', 'low-density lipoprotein particle receptor binding', 'unfolded protein binding', 'amyloid-beta binding', 'protein-containing complex binding', 'tau protein binding', 'misfolded protein binding']",1,1,0,1,1,1,1,2,4,6
377,DLGAP4,DLG associated protein 4 [Source:HGNC Symbol;Acc:HGNC:24476],"['protein binding', 'molecular adaptor activity']",1,0,1,1,1,1,1,2,4,6
378,PTPRA,protein tyrosine phosphatase receptor type A [Source:HGNC Symbol;Acc:HGNC:9664],"['protein binding', 'transmembrane receptor protein tyrosine phosphatase activity']",1,0,1,1,0,0,1,2,2,4
379,CPLX2,complexin 2 [Source:HGNC Symbol;Acc:HGNC:2310],"['syntaxin-1 binding', 'calcium-dependent protein binding']",1,1,1,1,1,0,0,3,2,5
380,SLC6A17,solute carrier family 6 member 17 [Source:HGNC Symbol;Acc:HGNC:31399],"['protein binding', 'symporter activity']",1,1,1,0,0,0,0,3,0,3
381,DNM1L,dynamin 1 like [Source:HGNC Symbol;Acc:HGNC:2973],"['small GTPase binding', 'lipid binding', 'BH2 domain binding', 'GTP-dependent protein binding', 'GTPase activator activity', 'ubiquitin protein ligase binding', 'clathrin binding', 'protein homodimerization activity', 'GTPase activity', 'microtubule binding', 'GTP binding', 'protein-containing complex binding']",1,1,1,1,1,1,1,3,4,7
382,ARFGAP1,ADP ribosylation factor GTPase activating protein 1 [Source:HGNC Symbol;Acc:HGNC:15852],"['GTPase activator activity', 'protein binding', 'metal ion binding']",1,0,1,1,0,0,1,2,2,4
383,APH1A,"aph-1 homolog A, gamma-secretase subunit [Source:HGNC Symbol;Acc:HGNC:29509]","['protein binding', 'endopeptidase activity']",1,0,1,0,0,0,0,2,0,2
384,RHEB,"Ras homolog, mTORC1 binding [Source:HGNC Symbol;Acc:HGNC:10011]","['protein kinase binding', 'magnesium ion binding', 'GDP binding', 'GTPase activity', 'GTP binding']",1,0,0,1,0,0,1,1,2,3
385,EIF5A,eukaryotic translation initiation factor 5A [Source:HGNC Symbol;Acc:HGNC:3300],"['U6 snRNA binding', 'ribosome binding', 'protein N-terminus binding', 'translation elongation factor activity']",1,1,0,0,0,0,0,2,0,2
386,EIF4EBP1,eukaryotic translation initiation factor 4E binding protein 1 [Source:HGNC Symbol;Acc:HGNC:3288],"['protein phosphatase 2A binding', 'translation repressor activity', 'eukaryotic initiation factor 4E binding']",1,0,0,0,0,0,0,1,0,1
387,OPRD1,opioid receptor delta 1 [Source:HGNC Symbol;Acc:HGNC:8153],"['enkephalin receptor activity', 'receptor serine/threonine kinase binding', 'neuropeptide binding']",1,0,1,0,0,0,0,2,0,2
388,SYT6,synaptotagmin 6 [Source:HGNC Symbol;Acc:HGNC:18638],"['calcium ion binding', 'syntaxin binding', 'calcium-dependent protein binding', 'clathrin binding', 'phosphatidylserine binding', 'protein homodimerization activity']",1,0,1,0,0,0,0,2,0,2
389,LZTS3,leucine zipper tumor suppressor family member 3 [Source:HGNC Symbol;Acc:HGNC:30139],None,1,0,0,0,0,0,0,1,0,1
390,CTBP1,C-terminal binding protein 1 [Source:HGNC Symbol;Acc:HGNC:2494],"['NAD binding', 'protein domain specific binding', 'oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor', 'identical protein binding', 'transcription corepressor activity', 'repressing transcription factor binding', 'RNA polymerase II transcription corepressor binding', 'chromatin binding', 'protein C-terminus binding']",1,1,1,1,0,1,1,3,3,6
391,RPS7,ribosomal protein S7 [Source:HGNC Symbol;Acc:HGNC:10440],"[""mRNA 3'-UTR binding"", 'protein kinase binding', 'ubiquitin ligase inhibitor activity', ""mRNA 5'-UTR binding"", 'structural constituent of ribosome']",1,1,0,1,1,0,1,2,3,5
392,RAB5A,"RAB5A, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9783]","['protein binding', 'GDP binding', 'GTP binding', 'GTPase activity']",1,1,1,1,1,0,1,3,3,6
393,RPL23,ribosomal protein L23 [Source:HGNC Symbol;Acc:HGNC:10316],"['transcription coactivator binding', 'ubiquitin protein ligase binding', 'large ribosomal subunit rRNA binding', 'ubiquitin ligase inhibitor activity', 'structural constituent of ribosome']",1,1,0,1,1,1,1,2,4,6
394,RPL37,ribosomal protein L37 [Source:HGNC Symbol;Acc:HGNC:10347],"['rRNA binding', 'structural constituent of ribosome', 'metal ion binding']",1,0,0,1,1,0,0,1,2,3
395,EPS15,epidermal growth factor receptor pathway substrate 15 [Source:HGNC Symbol;Acc:HGNC:3419],"['SH3 domain binding', 'calcium ion binding', 'cadherin binding', 'polyubiquitin modification-dependent protein binding', 'identical protein binding']",1,1,0,1,0,0,0,2,1,3
396,PTK2,protein tyrosine kinase 2 [Source:HGNC Symbol;Acc:HGNC:9611],"['SH2 domain binding', 'JUN kinase binding', 'actin binding', 'non-membrane spanning protein tyrosine kinase activity', 'integrin binding', 'ATP binding', 'protein phosphatase binding']",1,1,0,1,0,0,1,2,2,4
397,PPP1R9A,protein phosphatase 1 regulatory subunit 9A [Source:HGNC Symbol;Acc:HGNC:14946],"['ion channel binding', 'GTPase binding', 'protein domain specific binding', 'protein kinase binding', 'identical protein binding', 'actin filament binding', 'protein phosphatase 1 binding', 'protein C-terminus binding']",1,1,0,0,0,1,1,2,2,4
398,NCS1,neuronal calcium sensor 1 [Source:HGNC Symbol;Acc:HGNC:3953],"['magnesium ion binding', 'protein kinase binding', 'calcium ion binding', 'voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels']",1,0,0,0,0,0,0,1,0,1
399,CRKL,"CRK like proto-oncogene, adaptor protein [Source:HGNC Symbol;Acc:HGNC:2363]","['cadherin binding', 'RNA binding', 'identical protein binding', 'phosphotyrosine residue binding']",1,0,0,1,1,0,1,1,3,4
400,KCNC4,potassium voltage-gated channel subfamily C member 4 [Source:HGNC Symbol;Acc:HGNC:6236],"['protein binding', 'delayed rectifier potassium channel activity']",1,0,1,1,0,0,0,2,1,3
401,INA,internexin neuronal intermediate filament protein alpha [Source:HGNC Symbol;Acc:HGNC:6057],"['protein binding', 'structural constituent of postsynaptic intermediate filament cytoskeleton', 'structural constituent of postsynaptic actin cytoskeleton']",1,1,1,1,1,1,1,3,4,7
402,ATP6V1B2,ATPase H+ transporting V1 subunit B2 [Source:HGNC Symbol;Acc:HGNC:854],"['protein binding', 'proton-transporting ATPase activity, rotational mechanism', 'hydrolase activity', 'ATP binding']",1,1,1,1,1,1,1,3,4,7
403,PTPRO,protein tyrosine phosphatase receptor type O [Source:HGNC Symbol;Acc:HGNC:9678],"['protein homodimerization activity', 'cadherin binding', 'Wnt-protein binding', 'transmembrane receptor protein tyrosine phosphatase activity']",1,0,0,0,0,1,1,1,2,3
404,GRIN3B,glutamate ionotropic receptor NMDA type subunit 3B [Source:HGNC Symbol;Acc:HGNC:16768],"['neurotransmitter binding', 'glycine binding', 'calcium channel activity', 'NMDA glutamate receptor activity']",1,0,0,0,0,0,0,1,0,1
405,GABRB1,gamma-aminobutyric acid type A receptor subunit beta1 [Source:HGNC Symbol;Acc:HGNC:4081],"['GABA-gated chloride ion channel activity', 'transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential', 'GABA-A receptor activity', 'GABA receptor binding']",1,0,1,1,0,0,0,2,1,3
406,PACSIN1,protein kinase C and casein kinase substrate in neurons 1 [Source:HGNC Symbol;Acc:HGNC:8570],"['identical protein binding', 'phospholipid binding', 'cytoskeletal protein binding']",1,1,1,1,1,0,0,3,2,5
407,PCDH17,protocadherin 17 [Source:HGNC Symbol;Acc:HGNC:14267],"['protein binding', 'calcium ion binding']",1,0,0,0,0,0,1,1,1,2
408,ANXA5,annexin A5 [Source:HGNC Symbol;Acc:HGNC:543],"['protein binding', 'phospholipase inhibitor activity', 'calcium ion binding', 'calcium-dependent phospholipid binding']",1,1,1,0,0,0,1,3,1,4
409,SLC8A3,solute carrier family 8 member A3 [Source:HGNC Symbol;Acc:HGNC:11070],"['calmodulin binding', 'calcium:sodium antiporter activity', 'metal ion binding']",1,0,1,0,0,0,0,2,0,2
410,PPP1R1B,protein phosphatase 1 regulatory inhibitor subunit 1B [Source:HGNC Symbol;Acc:HGNC:9287],"['D4 dopamine receptor binding', 'D5 dopamine receptor binding', 'protein phosphatase inhibitor activity', 'D3 dopamine receptor binding', 'D1 dopamine receptor binding', 'protein kinase inhibitor activity', 'D2 dopamine receptor binding']",1,0,1,1,1,0,0,2,2,4
411,VAMP1,vesicle associated membrane protein 1 [Source:HGNC Symbol;Acc:HGNC:12642],"['SNAP receptor activity', 'syntaxin binding']",1,1,1,0,0,0,0,3,0,3
412,PICK1,protein interacting with PRKCA 1 [Source:HGNC Symbol;Acc:HGNC:9394],"['phospholipid binding', 'G protein-coupled receptor binding', 'protein domain specific binding', 'protein kinase C binding', 'identical protein binding', 'actin filament binding', 'metal ion binding', 'membrane curvature sensor activity', 'Arp2/3 complex binding', 'protein C-terminus binding']",1,0,1,0,0,0,1,2,1,3
413,CADPS2,calcium dependent secretion activator 2 [Source:HGNC Symbol;Acc:HGNC:16018],"['lipid binding', 'metal ion binding']",1,0,0,1,1,0,0,1,2,3
414,AGAP3,"ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 [Source:HGNC Symbol;Acc:HGNC:16923]","['GTPase activator activity', 'polyubiquitin modification-dependent protein binding', 'GTPase activity', 'metal ion binding', 'GTP binding']",1,1,0,1,1,1,1,2,4,6
415,DGKZ,diacylglycerol kinase zeta [Source:HGNC Symbol;Acc:HGNC:2857],"['NAD+ kinase activity', 'protein binding', 'diacylglycerol kinase activity', 'ATP binding', 'metal ion binding']",1,1,0,1,1,0,0,2,2,4
416,P2RX6,purinergic receptor P2X 6 [Source:HGNC Symbol;Acc:HGNC:8538],"['protein-containing complex binding', 'extracellularly ATP-gated cation channel activity', 'purinergic nucleotide receptor activity', 'ATP binding']",1,0,1,0,0,0,0,2,0,2
417,YES1,"YES proto-oncogene 1, Src family tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:12841]","['ion channel binding', 'epidermal growth factor receptor binding', 'enzyme binding', 'non-membrane spanning protein tyrosine kinase activity', 'phosphotyrosine residue binding', 'ATP binding']",1,1,0,0,0,1,1,2,2,4
418,DLG3,discs large MAGUK scaffold protein 3 [Source:HGNC Symbol;Acc:HGNC:2902],"['structural constituent of postsynaptic density', 'ubiquitin protein ligase binding', 'kinase binding', 'ionotropic glutamate receptor binding', 'PDZ domain binding', 'protein C-terminus binding', 'protein phosphatase binding']",1,1,1,1,1,1,0,3,3,6
419,GABRA1,gamma-aminobutyric acid type A receptor subunit alpha1 [Source:HGNC Symbol;Acc:HGNC:4075],"['GABA-gated chloride ion channel activity', 'inhibitory extracellular ligand-gated ion channel activity', 'GABA-A receptor activity', 'transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential', 'drug binding', 'benzodiazepine receptor activity']",1,1,1,1,0,0,0,3,1,4
420,RHOA,ras homolog family member A [Source:HGNC Symbol;Acc:HGNC:667],"['Rho GDP-dissociation inhibitor binding', 'protein domain specific binding', 'protein kinase binding', 'myosin binding', 'GDP binding', 'GTPase activity', 'GTP binding']",1,1,1,1,1,0,1,3,3,6
421,RAB17,"RAB17, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:16523]","['protein binding', 'GDP binding', 'GTP binding', 'GTPase activity']",1,0,0,0,0,0,0,1,0,1
422,EEF1D,eukaryotic translation elongation factor 1 delta [Source:HGNC Symbol;Acc:HGNC:3211],"['cadherin binding', 'DNA binding', 'guanyl-nucleotide exchange factor activity', 'translation elongation factor activity']",1,1,0,1,1,1,1,2,4,6
423,EPHA4,EPH receptor A4 [Source:HGNC Symbol;Acc:HGNC:3388],"['protein tyrosine kinase binding', 'DH domain binding', 'GPI-linked ephrin receptor activity', 'transmembrane-ephrin receptor activity', 'ephrin receptor binding', 'identical protein binding', 'ATP binding', 'amyloid-beta binding', 'PH domain binding']",1,1,1,1,1,0,1,3,3,6
424,GIT1,GIT ArfGAP 1 [Source:HGNC Symbol;Acc:HGNC:4272],"['GTPase activator activity', 'protein binding', 'protein-containing complex binding', 'metal ion binding']",1,1,1,1,1,1,1,3,4,7
425,RPH3A,rabphilin 3A [Source:HGNC Symbol;Acc:HGNC:17056],"['calcium-dependent phospholipid binding', 'zinc ion binding', 'calcium ion binding', 'phosphatidylinositol-4,5-bisphosphate binding', 'selenium binding', 'small GTPase binding', 'protein-containing complex binding', 'phosphate ion binding', 'inositol 1,4,5 trisphosphate binding']",1,1,1,1,1,0,0,3,2,5
426,HTR3A,5-hydroxytryptamine receptor 3A [Source:HGNC Symbol;Acc:HGNC:5297],"['protein binding', 'serotonin-gated cation-selective channel activity', 'serotonin binding', 'transmembrane signaling receptor activity']",1,0,1,0,0,0,0,2,0,2
427,STX6,syntaxin 6 [Source:HGNC Symbol;Acc:HGNC:11441],"['SNAP receptor activity', 'syntaxin binding']",1,1,1,1,0,0,0,3,1,4
428,DOCK10,dedicator of cytokinesis 10 [Source:HGNC Symbol;Acc:HGNC:23479],"['protein binding', 'guanyl-nucleotide exchange factor activity']",1,1,0,0,0,0,0,2,0,2
429,ANO2,anoctamin 2 [Source:HGNC Symbol;Acc:HGNC:1183],"['intracellular calcium activated chloride channel activity', 'identical protein binding', 'protein dimerization activity']",1,0,0,0,0,0,0,1,0,1
430,OLFM1,olfactomedin 1 [Source:HGNC Symbol;Acc:HGNC:17187],['protein binding'],1,1,1,1,1,0,1,3,3,6
431,CADPS,calcium dependent secretion activator [Source:HGNC Symbol;Acc:HGNC:1426],"['protein kinase binding', 'lipid binding', 'metal ion binding']",1,1,1,1,1,0,1,3,3,6
432,RPL18A,ribosomal protein L18a [Source:HGNC Symbol;Acc:HGNC:10311],"['protein binding', 'RNA binding', 'structural constituent of ribosome']",1,0,0,1,1,1,1,1,4,5
433,LAMA5,laminin subunit alpha 5 [Source:HGNC Symbol;Acc:HGNC:6485],"['integrin binding', 'extracellular matrix structural constituent']",1,0,0,0,0,0,1,1,1,2
434,LYN,"LYN proto-oncogene, Src family tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:6735]","['ion channel binding', 'SH3 domain binding', 'phosphorylation-dependent protein binding', 'platelet-derived growth factor receptor binding', 'ubiquitin protein ligase binding', 'ephrin receptor binding', 'non-membrane spanning protein tyrosine kinase activity', 'integrin binding', 'glycosphingolipid binding', 'gamma-tubulin binding', 'ATP binding', 'phosphoprotein binding']",1,1,0,0,0,1,1,2,2,4
435,SLC18A2,solute carrier family 18 member A2 [Source:HGNC Symbol;Acc:HGNC:10935],"['serotonin:sodium symporter activity', 'protein binding']",1,1,1,0,0,0,0,3,0,3
436,CACNA1B,calcium voltage-gated channel subunit alpha1 B [Source:HGNC Symbol;Acc:HGNC:1389],"['calcium ion binding', 'ATP binding', 'amyloid-beta binding', 'protein C-terminus binding', 'high voltage-gated calcium channel activity']",1,0,1,1,1,0,1,2,3,5
437,CYFIP2,cytoplasmic FMR1 interacting protein 2 [Source:HGNC Symbol;Acc:HGNC:13760],['small GTPase binding'],1,1,0,1,1,1,1,2,4,6
438,NOS1AP,nitric oxide synthase 1 adaptor protein [Source:HGNC Symbol;Acc:HGNC:16859],['nitric-oxide synthase binding'],1,0,0,0,0,0,0,1,0,1
439,STX3,syntaxin 3 [Source:HGNC Symbol;Acc:HGNC:11438],"['SNARE binding', 'SNAP receptor activity', 'arachidonic acid binding']",1,0,1,0,0,0,0,2,0,2
440,PHB2,prohibitin 2 [Source:HGNC Symbol;Acc:HGNC:30306],"['estrogen receptor binding', 'protein N-terminus binding', 'protein homodimerization activity', 'amide binding', 'protein heterodimerization activity', 'sphingolipid binding', 'protein C-terminus binding']",1,1,0,1,1,1,1,2,4,6
441,PTEN,phosphatase and tensin homolog [Source:HGNC Symbol;Acc:HGNC:9588],"['phosphatidylinositol-3-phosphatase activity', 'protein tyrosine kinase binding', 'lipid binding', 'protein tyrosine phosphatase activity', 'protein serine phosphatase activity', 'platelet-derived growth factor receptor binding', 'protein tyrosine/serine/threonine phosphatase activity', 'protein threonine phosphatase activity', 'identical protein binding', 'inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity', 'phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity', 'anaphase-promoting complex binding', 'phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity', 'PDZ domain binding', 'ubiquitin-specific protease binding', 'ionotropic glutamate receptor binding']",1,0,0,0,0,0,1,1,1,2
442,FKBP1A,FKBP prolyl isomerase 1A [Source:HGNC Symbol;Acc:HGNC:3711],"['ion channel binding', 'SMAD binding', 'peptidyl-prolyl cis-trans isomerase activity', 'FK506 binding', 'type I transforming growth factor beta receptor binding', 'activin binding']",1,0,1,1,1,0,0,2,2,4
443,EEF2K,eukaryotic elongation factor 2 kinase [Source:HGNC Symbol;Acc:HGNC:24615],"['calmodulin binding', 'calcium ion binding', 'elongation factor-2 kinase activity', 'translation factor activity, RNA binding', 'ATP binding']",1,0,0,0,0,0,0,1,0,1
444,HTR2A,5-hydroxytryptamine receptor 2A [Source:HGNC Symbol;Acc:HGNC:5293],"['G-protein alpha-subunit binding', '1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding', 'virus receptor activity', 'neurotransmitter receptor activity', 'Gq/11-coupled serotonin receptor activity', 'serotonin binding', 'identical protein binding', 'protein-containing complex binding']",1,0,1,0,0,0,0,2,0,2
445,SEMA4B,semaphorin 4B [Source:HGNC Symbol;Acc:HGNC:10730],"['chemorepellent activity', 'semaphorin receptor binding']",1,0,0,0,0,0,0,1,0,1
446,ARHGDIA,Rho GDP dissociation inhibitor alpha [Source:HGNC Symbol;Acc:HGNC:678],"['GTPase activator activity', 'small GTPase binding', 'Rho GDP-dissociation inhibitor activity']",1,1,1,1,1,1,1,3,4,7
447,MAP2K1,mitogen-activated protein kinase kinase 1 [Source:HGNC Symbol;Acc:HGNC:6840],"['protein tyrosine kinase activity', 'protein serine/threonine kinase activity', 'protein N-terminus binding', 'scaffold protein binding', 'ATP binding', 'MAP-kinase scaffold activity', 'protein serine/threonine kinase activator activity', 'MAP kinase kinase activity', 'protein C-terminus binding']",1,1,1,1,1,0,1,3,3,6
448,PRRT2,proline rich transmembrane protein 2 [Source:HGNC Symbol;Acc:HGNC:30500],"['SH3 domain binding', 'syntaxin-1 binding']",1,0,0,1,1,0,1,1,3,4
449,CDH2,cadherin 2 [Source:HGNC Symbol;Acc:HGNC:1759],"['calcium ion binding', 'cadherin binding', 'protein kinase binding', 'alpha-catenin binding', 'identical protein binding', 'gamma-catenin binding', 'beta-catenin binding', 'protein phosphatase binding']",1,1,1,1,1,1,1,3,4,7
450,PLEKHA5,pleckstrin homology domain containing A5 [Source:HGNC Symbol;Acc:HGNC:30036],"['phosphatidylinositol-5-phosphate binding', 'phosphatidylinositol-4-phosphate binding', 'protein binding', 'phosphatidylinositol-3-phosphate binding', 'phosphatidylinositol-3,5-bisphosphate binding']",1,1,0,0,0,1,1,2,2,4
451,GSK3B,glycogen synthase kinase 3 beta [Source:HGNC Symbol;Acc:HGNC:4617],"['protein serine kinase activity', 'p53 binding', 'protein kinase A catalytic subunit binding', 'ubiquitin protein ligase binding', 'RNA polymerase II transcription factor binding', 'tau protein binding', 'ATP binding', 'tau-protein kinase activity', 'protein threonine kinase activity', 'dynactin binding', 'protease binding', 'NF-kappaB binding', 'beta-catenin binding']",1,1,1,1,1,1,1,3,4,7
452,TNC,tenascin C [Source:HGNC Symbol;Acc:HGNC:5318],"['syndecan binding', 'extracellular matrix structural constituent']",1,1,0,1,0,1,1,2,3,5
453,CADM1,cell adhesion molecule 1 [Source:HGNC Symbol;Acc:HGNC:5951],"['protein homodimerization activity', 'PDZ domain binding', 'signaling receptor binding']",1,0,1,1,0,0,1,2,2,4
454,PUM2,pumilio RNA binding family member 2 [Source:HGNC Symbol;Acc:HGNC:14958],"[""mRNA 3'-UTR binding"", 'protein binding', 'miRNA binding']",1,0,0,1,0,0,1,1,2,3
455,ATP6V0A1,ATPase H+ transporting V0 subunit a1 [Source:HGNC Symbol;Acc:HGNC:865],"['ATPase binding', 'proton-transporting ATPase activity, rotational mechanism']",1,1,1,1,1,1,1,3,4,7
456,ARC,activity regulated cytoskeleton associated protein [Source:HGNC Symbol;Acc:HGNC:648],"['protein binding', 'mRNA binding']",1,1,0,0,0,0,0,2,0,2
457,LRRC4,leucine rich repeat containing 4 [Source:HGNC Symbol;Acc:HGNC:15586],['protein binding'],1,0,0,0,0,0,0,1,0,1
458,PRKCA,protein kinase C alpha [Source:HGNC Symbol;Acc:HGNC:9393],"['zinc ion binding', 'enzyme binding', 'calcium-dependent protein kinase C activity', 'integrin binding', 'histone kinase activity (H3-T6 specific)', 'ATP binding']",1,1,1,1,1,0,1,3,3,6
459,RPS24,ribosomal protein S24 [Source:HGNC Symbol;Acc:HGNC:10411],"['RNA binding', 'translation initiation factor binding', 'structural constituent of ribosome']",1,0,0,1,0,0,1,1,2,3
460,CYTH2,cytohesin 2 [Source:HGNC Symbol;Acc:HGNC:9502],"['protein binding', 'guanyl-nucleotide exchange factor activity', 'lipid binding', 'inositol 1,4,5 trisphosphate binding']",1,0,0,1,0,1,1,1,3,4
461,FYN,"FYN proto-oncogene, Src family tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:4037]","['alpha-tubulin binding', 'ion channel binding', 'peptide hormone receptor binding', 'tau-protein kinase activity', 'growth factor receptor binding', 'CD4 receptor binding', 'CD8 receptor binding', 'type 5 metabotropic glutamate receptor binding', 'T cell receptor binding', 'enzyme binding', 'phosphatidylinositol 3-kinase binding', 'non-membrane spanning protein tyrosine kinase activity', 'identical protein binding', 'ephrin receptor binding', 'ATP binding', 'metal ion binding', 'disordered domain specific binding', 'tau protein binding']",1,1,0,1,1,1,1,2,4,6
462,P2RX1,purinergic receptor P2X 1 [Source:HGNC Symbol;Acc:HGNC:8533],"['zinc ion binding', 'purinergic nucleotide receptor activity', 'identical protein binding', 'extracellularly ATP-gated cation channel activity', 'ATP binding', 'protein-containing complex binding', 'drug binding']",1,0,1,0,0,0,0,2,0,2
463,SYN3,synapsin III [Source:HGNC Symbol;Acc:HGNC:11496],['ATP binding'],1,1,1,1,1,1,1,3,4,7
464,GPHN,gephyrin [Source:HGNC Symbol;Acc:HGNC:15465],"['molybdopterin molybdotransferase activity', 'identical protein binding', 'ATP binding', 'metal ion binding', 'molybdopterin adenylyltransferase activity', 'molybdopterin cofactor binding', 'nitrate reductase activity']",1,1,0,1,1,1,1,2,4,6
465,SYP,synaptophysin [Source:HGNC Symbol;Acc:HGNC:11506],"['SH2 domain binding', 'identical protein binding', 'syntaxin-1 binding', 'cholesterol binding', 'protein self-association']",1,1,1,0,1,1,1,3,3,6
466,RPS27A,ribosomal protein S27a [Source:HGNC Symbol;Acc:HGNC:10417],"['ubiquitin protein ligase binding', 'structural constituent of ribosome', 'metal ion binding', 'RNA binding', 'protein tag']",1,1,1,1,0,0,0,3,1,4
467,VPS16,VPS16 core subunit of CORVET and HOPS complexes [Source:HGNC Symbol;Acc:HGNC:14584],['actin filament binding'],1,0,0,1,0,1,1,1,3,4
468,DMD,dystrophin [Source:HGNC Symbol;Acc:HGNC:2928],"['zinc ion binding', 'dystroglycan binding', 'nitric-oxide synthase binding', 'structural constituent of muscle', 'actin binding', 'myosin binding', 'vinculin binding', 'structural constituent of cytoskeleton']",1,0,0,1,1,0,0,1,2,3
469,GRM7,glutamate metabotropic receptor 7 [Source:HGNC Symbol;Acc:HGNC:4599],"['serine binding', 'adenylate cyclase inhibitor activity', 'group III metabotropic glutamate receptor activity']",1,1,1,1,0,0,0,3,1,4
470,KLHL17,kelch like family member 17 [Source:HGNC Symbol;Acc:HGNC:24023],"['molecular adaptor activity', 'actin filament binding', 'POZ domain binding']",1,0,0,0,0,0,0,1,0,1
471,SPTBN2,"spectrin beta, non-erythrocytic 2 [Source:HGNC Symbol;Acc:HGNC:11276]","['phospholipid binding', 'cadherin binding', 'structural constituent of synapse', 'actin binding', 'structural constituent of cytoskeleton']",1,1,1,0,0,1,1,3,2,5
472,PFN1,profilin 1 [Source:HGNC Symbol;Acc:HGNC:8881],"['actin monomer binding', 'small GTPase binding', 'proline-rich region binding', 'cadherin binding', 'phosphatidylinositol-4,5-bisphosphate binding', 'phosphotyrosine residue binding', 'adenyl-nucleotide exchange factor activity', 'RNA binding', 'signaling receptor binding']",1,1,1,0,0,0,0,3,0,3
473,RPL21,ribosomal protein L21 [Source:HGNC Symbol;Acc:HGNC:10313],"['protein binding', 'RNA binding', 'structural constituent of ribosome']",1,0,0,1,1,0,1,1,3,4
474,EPS15L1,epidermal growth factor receptor pathway substrate 15 like 1 [Source:HGNC Symbol;Acc:HGNC:24634],"['cadherin binding', 'calcium ion binding']",1,0,0,1,1,1,1,1,4,5
475,RAB6A,"RAB6A, member RAS oncogene family [Source:HGNC Symbol;Acc:HGNC:9786]","['myosin V binding', 'GTP binding', 'protein domain specific binding', 'GTPase activity']",1,1,1,1,1,0,1,3,3,6
476,GRM5,glutamate metabotropic receptor 5 [Source:HGNC Symbol;Acc:HGNC:4597],"['protein tyrosine kinase binding', 'protein tyrosine kinase activator activity', 'neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration', 'glutamate receptor activity', 'identical protein binding', 'G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential']",1,1,1,1,1,0,0,3,2,5
477,KCNAB2,potassium voltage-gated channel subfamily A regulatory beta subunit 2 [Source:HGNC Symbol;Acc:HGNC:6229],"['ion channel binding', 'potassium channel regulator activity', 'aldo-keto reductase (NADP) activity', 'voltage-gated potassium channel activity']",1,1,1,1,1,0,0,3,2,5
478,SCN11A,sodium voltage-gated channel alpha subunit 11 [Source:HGNC Symbol;Acc:HGNC:10583],"['voltage-gated sodium channel activity', 'voltage-gated ion channel activity']",1,0,0,0,0,0,0,1,0,1
479,GRID2,glutamate ionotropic receptor delta type subunit 2 [Source:HGNC Symbol;Acc:HGNC:4576],"['ionotropic glutamate receptor activity', 'PDZ domain binding', 'transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential', 'scaffold protein binding']",1,1,0,0,0,0,0,2,0,2
480,KCNMA1,potassium calcium-activated channel subfamily M alpha 1 [Source:HGNC Symbol;Acc:HGNC:6284],"['large conductance calcium-activated potassium channel activity', 'voltage-gated potassium channel activity', 'actin binding', 'metal ion binding']",1,1,1,1,1,0,0,3,2,5
481,RPL3,ribosomal protein L3 [Source:HGNC Symbol;Acc:HGNC:10332],"['protein binding', '5S rRNA binding', 'structural constituent of ribosome']",1,0,0,1,1,1,1,1,4,5
482,RPSA,ribosomal protein SA [Source:HGNC Symbol;Acc:HGNC:6502],"['virus receptor activity', 'ribosome binding', 'structural constituent of ribosome', 'RNA binding', 'laminin binding', 'laminin receptor activity']",1,1,0,1,1,1,1,2,4,6
483,RPL31,ribosomal protein L31 [Source:HGNC Symbol;Acc:HGNC:10334],"['protein binding', 'RNA binding', 'structural constituent of ribosome']",1,1,0,1,1,0,1,2,3,5
484,CORO1A,coronin 1A [Source:HGNC Symbol;Acc:HGNC:2252],"['actin monomer binding', 'phosphatidylinositol 3-kinase binding', 'protein homodimerization activity', 'actin filament binding', 'myosin heavy chain binding', 'RNA binding', 'protein C-terminus binding']",1,1,1,1,1,1,1,3,4,7
485,RPL10A,ribosomal protein L10a [Source:HGNC Symbol;Acc:HGNC:10299],"['protein binding', 'RNA binding', 'structural constituent of ribosome']",1,1,0,1,1,1,1,2,4,6
486,FILIP1,filamin A interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:21015],None,1,0,0,0,0,0,0,1,0,1
